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A functional protein quality control machinery is crucial to maintaining cellular 
and organismal physiology. Perturbation in the protein homeostasis network 
can lead to the formation of misfolded and aggregated proteins that are a 
hallmark of protein conformational disorders and aging. Protein aggregation is 
counteracted by the action of chaperones that can resolubilize aggregated 
proteins. An alternative protein clearance strategy is the elimination by 
proteolysis employing the ubiquitin-proteasome system (UPS) or autophagy. 
Little is known how these three protein aggregate clearance strategies are 
regulated and coordinated in an organismal level with the progression of aging 
or upon expression of disease-associated proteins.  
In this study, I aimed to unravel the crosstalk between the different clearance 
options. To address this, I investigated how autophagy and UPS respond to the 
expression of disease-associated proteins and during aging when the 
chaperone capacity is compromised in C. elegans and HEK293 cells. Here, I 
demonstrate that wild-type animals display a reduced autophagic flux with the 
progression of aging whereas the UPS activity is altered in a tissue-specific 
manner (reduced activity in the neuronal cells and increased activity in the 
muscle cells). A knockdown of chaperones that constitute the HSP110/70/J 
disaggregation complex leads to an activation of autophagy that probably 
serves as a compensatory mechanism to rebalance proteostasis. Notably, the 
compensatory effect of autophagy in response to a depletion of chaperones is 
diminished with the progression of aging in C. elegans. Interestingly, the 
proteasomal activity and 20S levels are reduced in response to chaperone 
depletion, in particular upon knockdown of hsp-110/hspa4.  
Moreover, the capacity of the clearance machinery was analyzed in 
neurodegenerative disease models. The expression of aggregation-prone and 
disease-associated Aβ and polyglutamine (Q40) proteins leads to an impairment 
of both proteolytic pathways. Notably, the expression of Aβ perturbs the 
proteasome system also in a distal tissue demonstrating a trans-tissue 
communication. Lastly, in order to better understand how amyloid aggregates 
affect the cellular environment, correlative light and electron microscopy studies 
were performed in C. elegans. The Q40 aggregates display an amyloid structure 
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and are not enclosed by any membrane. The lack of a surrounding membrane 
exposes the aggregate to all cellular components, which allows it to sequester 
numerous cellular components. 
The results obtained in this thesis, further elucidate the tight coordination 
between the different nodes of the proteostasis network with the progression of 
aging and disease on a cellular and organismal level.  
 
Keywords: C. elegans, Proteostasis, Chaperones, Autophagy, Ubiquitin-




Eine funktionelle Proteinqualitätskontrolle ist essentiell, um die 
Funktionstüchtigkeit jeder einzelnen Zelle und des gesamten Organismus 
aufrecht zu halten. Beeinträchtigungen der Proteinhomöostase können zu 
Proteinmisfaltungen und schließlich auch zur Bildung von Proteinaggregaten 
führen. Proteinaggregate treten vermehrt im Alter auf und sind auch ein 
Charakteristikum von neurodegenerativen Erkrankungen.  Molekulare 
Chaperone können die Bildung von Proteinaggregaten unterdrücken und 
bestehende Aggregate auch resolubilisieren. Eine alternative Strategie, 
Proteinaggregate zu eliminieren ist der proteolytische Abbau durch das 
Proteasom oder über Autophagie. Unser Wissen, wie diese Strategien zum 
Abbau oder der Auflösung der Aggregate mit dem Alter oder nach Expression 
von krankheitsassoziierten Proteinen koordiniert werden, ist sehr limitiert.  
An dieser Fragestellung setzte meine Arbeit an und ich untersuchte, wie die 
verschiedenen Proteinabbaumechanismen koordiniert werden. Dazu 
analysierte ich die Aktivität der Autophagie und auch des Proteasoms nach 
Depletion disaggregierender Chaperone, nach Expression von amyloiden 
krankheitsassoziierten Proteinen und mit fortschreitendem Alter im Nematoden 
C. elegans und in HEK293 Zellen. Ich konnte zeigen, dass die Aktivität der 
Autophagie mit dem Alter abnimmt, das Proteasom jedoch gewebsspezifisch 
reguliert wird und in alternden Neuronen an Aktivität abnimmt, im Muskel jedoch 
aktiver wird. Eine Depletion der Chaperone, die für die Disaggregation von 
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Proteinaggregaten verantwortlich sind, führt zu einer Aktivierung der 
Autophagie. Der kompensatorische Effekt der Autophagie nach 
Beeinträchtigung der Disaggregation ist jedoch auf die reproduktive Phase des 
Tiers beschränkt. Mit fortschreitendem Alter, nimmt die Aktivierung der 
Autophagie in C. elegans ab. Interessanterweise kommt es nach Depletion der 
disaggregierenden Chaperone zu einer Reduktion der 20S Untereinheiten und 
damit einhergehenden verminderten Aktivität des Proteasoms. Dieser Effekt ist 
besonders nach Depletion von hsp-110/hspa4 ausgeprägt.  
Die Expression von amyloiden krankheitsassoziierten Proteinen wie 
beispielsweise Aβ und polyQ führt zu einer Beeinträchtigung von beiden 
proteolytischen Abbaumechanismen. Ich konnte zudem beobachten, dass 
Aβ das Proteasom auch in benachbarten Geweben, in denen Aβ nicht 
exprimiert wird, inhibiert. Dieser gewebsübergreifende proteotoxische Effekt 
deutet auf systemische Beeinträchtigungen nach Aβ Expression hin.  Um 
einen Einblick zu gewinnen wie amyloide Proteinaggregate zelluläre Funktionen 
beeinflussen, habe ich die Ultrastruktur von Q40 Proteinaggregaten 
elektronenmikroskopisch im Nematoden untersucht. Mittels korrelativer Licht 
und Elektronenmikroskopie (CLEM) und Elektronenmikroskopie (EM) konnte ich 
die Ultrastruktur der Amyloidfibrillen von Q40 Proteinaggregaten erstmalig im 
Tiermodell darstellen und auch zeigen, dass die Aggregate in vivo nicht 
membranumschlossen sind. Die amyloiden Proteinaggregate können so leicht 
zelluläre Komponenten wie beispielsweise endogene Proteine sequestrieren 
und so deren physiologische Funktion in der Zelle beeinträchtigen.  
Die Ergebnisse dieser Arbeit ermöglichen mechanistische Einblicke in die 
Regulation der verschiedenen Strategien zum Abbau von Proteinaggregaten 
mit fortschreitendem Alter und nach Expression krankheitsassoziierter 
amyloider Proteine. 
 
Stichworte: C. elegans, Proteostase, Chaperone, Autophagie, Ubiquitin-






3.1 Proteostasis Network 
The maintenance of a functional proteome is critical for the cellular and 
organismal physiology. Mammalian cells are composed of around 20.000 
distinct proteins that support protein homeostasis (proteostasis) by playing key 
roles in the immune system, signaling pathways, metabolism and cellular 
structures (Reszka et al. 1995, Miners et al. 1998, Schlessinger 2000, Lemmon 
et al. 2010, Balchin et al. 2016). Proteins are synthesized by the ribosome and 
to be fully functional they must achieve its three-dimensional structure (Figure 
1.1) (Balchin et al. 2016). Despite the specific protein folding being determined 
by the amino acid sequence, proteins need to overcome many challenges to 
achieve the correct folding (Anfinsen et al. 1961). Cellular crowding is one of 
the major barriers that proteins face in order to achieve a correct folding (Ellis 
2001). The high cellular protein concentration (200-300 g/l) is known to perturb 
protein folding, and consequently promotes protein misfolding and aggregation 
(Ellis et al. 2006, Kim et al. 2013). 
To preserve a healthy cellular environment, cells must achieve a balance 
between protein synthesis and degradation (Figure 1.1) (Kim et al. 2013). 
Proteins can misfold and aggregate due to many factors, but this occurs mainly 
in response to acute stress such as oxidative and heat stress, or protein 
mutations (Lindquist 1986, Ellis et al. 2006). Protein aggregates may exhibit 
different structures depending on the type of stress. While the aggregates 
generated after heat stress display an amorphous structure, mutations in 
specific proteins can lead to the formation of amyloid aggregates (Stranks et al. 
2009, Tyedmers et al. 2010). The latter is the hallmark of many 
neurodegenerative diseases like Alzheimer, Parkinson, and Huntington’s 
disease (Nozaki et al. 2001, Carnini et al. 2012, Gao et al. 2015). In each of 
these neurodegenerative diseases, specific proteins are mutated and form 
amyloid fibrils that are defined by the extension of many beta-sheet structures 
(Balchin et al. 2016). 
Cells are equipped with a proteostasis network (PN) that safeguards the 
proteome and regulates the correct fold and function of all proteins (Morimoto et 
al. 2014). The PN is composed of molecular chaperones that ensure the native 
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state of proteins by assisting de novo folding, protein refolding and 
disaggregation, and also proteolytic clearance pathways such as the autophagy 
and the ubiquitin-proteasome system (UPS) that eliminate non-functional 
cellular components (Figure 1.1). A tight regulation between the different 
proteostasis members is critical to the preservation of a balanced protein 
homeostasis both on a cellular and organismal level (Wolff et al. 2014, Kaushik 




Figure 1. 1 - Proteostasis overview. 
Proteins are synthesized at the ribosome and fold into its native state. However, 
proteins may misfold due to various factors (e.g. heat stress). Chaperones assist not 
only in the initial folding events, but also in the refolding of misfolded proteins. In 
particular cases, the misfolded proteins accumulate and form amorphous or amyloid 
aggregates. Disaggregating chaperones (e.g. HSP110/70/J complex) can prevent and 
also revert protein aggregation (amorphous and amyloid aggregates). Protein 
aggregates can also be eliminated by proteolytic clearance pathways such as 





3.1.1 Molecular Chaperones 
Molecular chaperones were found to be critical in protein folding events as they 
support de novo folding and stabilize the structure of other proteins, without 
participating in the final protein structure (Ellis 1987, Hartl 1996). Molecular 
chaperones already assist the folding of nascent chains that emerge from the 
exit tunnel of the ribosome (Hoffmann et al. 2012). The crowded cellular 
environment however favors non-native interactions of the nascent chain, which 
potentially leads to protein misfolding (Anfinsen 1973, Zhou 2008, Zhou et al. 
2009).  
Molecular chaperones are known as Heat-shock proteins (Hsp), and were 
historically categorized based on their molecular weight into distinct families e.g. 
small heat-shock proteins (sHsp), Hsp60, Hsp70, Hsp90 and Hsp100s (Hartl 
1996, Hartl et al. 2011, Kim et al. 2013). sHsps are known to function as 
holdases (ATP-independent), and Hsp60, Hsp70, Hsp90 and Hsp110 as 
foldases (ATP-dependent) (Taipale et al. 2010, Mayer 2013, Treweek et al. 
2015). Despite the nomenclature, heat-shock proteins are not only induced 
upon heat shock. For instance, the important cytosolic Hsc70 is constitutively 
expressed under physiological conditions (Kim et al. 2013). Moreover, virus 
infection or oxidative stress can also induce chaperone expression (Tardif et al. 
2002, Park et al. 2009). 
Chaperones are a highly diverse family encoding for more than 300 and 200 
different proteins in humans and nematodes, respectively. As a consequence of 
the diversity of the heat-shock protein family, multiple biological processes 
require the action of Hsps, such as protein folding, refolding, degradation or 
disaggregation (Agarraberes et al. 2001, Demand et al. 2001, Otto et al. 2005, 
Rampelt et al. 2012).   
 
 
3.1.1.1 Chaperone-mediated protein disaggregation  
Disaggregation of protein aggregates facilitates the recovery from proteotoxic 
conditions such as heat stress that lead to an accumulation of misfolded and 
aggregated proteins (Glover et al. 1998, Mogk et al. 1999, Weibezahn et al. 
2004). Many organisms are reported to display a coordinated chaperone-
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mediated protein disaggregation. The work developed in Lindquist laboratory 
shed light into this mechanism in yeast, by demonstrating the critical role of 
Hsp104 disaggregase in developing tolerance and recovering cells from severe 
heat stress (Sanchez et al. 1990, Lindquist et al. 1996). Hsp104 (ClpB in E. Coli) 
is an Hsp100 member of the triple ATPase complex protein family (AAA+), and 
remodel protein substrates by using the energy derived from ATP hydrolysis 
(Parsell et al. 1994, Mogk et al. 1999). 
Humans and C. elegans do not have homologs of Hsp104/ClpB in their cytosol. 
Instead, disaggregation events are coordinated by a trimeric chaperone 
complex, which is composed of members of the Hsp70, J-protein and Hsp110 
chaperone families (Figure 1.2) (Shorter 2011, Rampelt et al. 2012). 
HSP110/70/J chaperone complex can suppress aggregation and promote 
disaggregation of amorphous (e.g. luciferase), as well as disease-associated 
amyloid aggregates (e.g. α-synuclein, α-syn, or huntingtin with abnormal 
polyglutamine repetitions, mHtt) (Rampelt et al. 2012, Gao et al. 2015, 
Nillegoda et al. 2015, Kirstein et al. 2017, Scior et al. 2018).  
 
 
3.1.1.2 HSP110/70/J chaperone disaggregation complex 
The Hsp70 family protein members play a central role in cellular protein 
homeostasis as they are involved in the folding and assembly of newly 
synthesized proteins, protein transport, prevention of protein misfolding, 
disaggregation of aggregated proteins, and targeting of misfolded proteins for 
degradation (Mayer et al. 2005). Humans and C. elegans encode for 13 and 9 
different Hsp70 family members, respectively (Heschl et al. 1989, Hageman et 
al. 2009). The Hsp70 chaperones are composed of two domains, the N-terminal 
nucleotide-binding domain and the C-terminal substrate-binding domain that are 
connected by a hydrophobic linker (Kumar et al. 2011, Mayer 2013). Hsp70s 
bind hydrophobic regions of five amino acids (aa) with adjacent positively 
charged aa that are exposed in misfolded proteins (Fourie et al. 1994, Rudiger 
et al. 1997). The chaperone activity of Hsp70 is enabled by the hydrolysis of 
ATP in the N-terminal domain that causes a conformational change in the C-
terminal substrate binding domain, leading to an increased substrate affinity of 
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Hsp70 in the ADP-bound state (Mayer et al. 2005, Zhuravleva et al. 2012, Kityk 
et al. 2015). Initial substrate recruitment and binding are facilitated by a co-
chaperone (J-protein) that accelerates the ATP hydrolysis (more than 100-fold), 
and consequently changes the Hsp70 substrate binding state from an open to a 
closed conformation, keeping the substrate bound to Hsp70 (Figure 1.2) 
(Laufen et al. 1999, Kampinga et al. 2010).  
The release of substrates is mediated by nucleotide exchange factors (NEF) 
such as proteins with a Bcl-2 associated anthanogene (BAG) domain, HSPBP1 
and Hsp110s (HSPA4 in humans or HSP-110 in C. elegans) that dissociate 
ADP and allow subsequent rebinding of ATP, resetting the Hsp70 chaperone to 
the open conformation (Laufen et al. 1999, Raviol et al. 2006, Rampelt et al. 
2012). The role of NEFs is essential in the disaggregation process as it 
regulates the substrate release from the Hsp70 complex and consequently 
enables the substrates to enter another folding cycle (Figure 1.2) (Bracher et al. 
2015). 
As mentioned above the Hsp70 chaperone activity is facilitated by the co-
chaperones, J-proteins, that recognize and deliver substrates to Hsp70. 
Previously known as Hsp40s, they are a highly diverse family, composed of 32 
and 49 members in nematodes and humans, respectively (Hageman et al. 2009, 
Craig et al. 2017). J-protein family members are divided into classes due to the 
presence of specific domains (class A, B, C or type-I, II, III). While type-I 
members contain a glycine-phenylalanine-rich motif, a zinc finger domain and a 
C-terminal domain that is important for dimerization and substrate binding, type-
II members lack the zinc-finger domain. J-proteins that do not share similarities 
in the C- and N-terminal domains with type-I/II are classified as type-III 
(Nillegoda et al. 2017). All classes display a highly conserved J-domain, 
composed of 70 aa that contains a Histidine-Proline-Aspartate (HPD) motif, 
essential for the acceleration of the ATP hydrolysis of Hsp70s (Tsai et al. 1996, 





Figure 1. 2 - HSP110/70/J disaggregation cycle. 
J-proteins bind and deliver client proteins to Hsp70 (1). The binding of the J-domain 
stimulates the HSP-70 ATPase hydrolysis leading to a conformational change (closed 
state) of HSP-70 (2). Upon binding of HSP-110 (3), ADP is replaced by ATP (4), which 
again alters the conformation (open state) of HSP-70 (5). If the client protein is 
correctly folded it is released (7) or if the folding was not successful it can enter a new 
folding cycle (6).  
 
 
J-proteins exhibit substrate preferences and can also cooperate with other 
members of the J-protein family and thereby regulate the activity of Hsp70 for 
respective substrates and also chaperone activity (Table 1). Amorphous 
aggregates, such as malate dehydrogenase and luciferase aggregates can be 
re-solubilized by DNJ-12 (DNAJA1 in humans, type-I) or by DNJ-13 (DNAJB1 in 
humans, type-II) together with HSP-70/HSP-110 (HSPA8/HSPA4 in humans). 
However, when DNJ-12 and DNJ-13 are combined with HSP-70/HSP-110, a 
more powerful disaggregation beyond an additive yield is accomplished 
(Rampelt et al. 2012, Nillegoda et al. 2015, Kirstein et al. 2017). This shows that 
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type-I and type-II J-proteins act synergistically when disaggregating amorphous 
aggregates. The HSP110/70/J chaperone complex can also disaggregate 
amyloid-like aggregates associated with neurodegenerative diseases. In this 
case, the action of HSP-70, HSP-110 together with a single type II J-protein, 
DNJ-13/DNAJB1, is sufficient to disaggregate aggregates formed by α-syn and 
mHtt (Gao et al. 2015, Scior et al. 2018). The addition of a type I J-protein to an 
Hsp70/type II J-protein mixture reduces the efficiency of the disaggregation 
activity probably due to competition for Hsp70 binding. Furthermore, it has been 
reported that early onset spinocerebellar ataxia 3 patients exhibit decreased 
levels of DNJAB1, pointing to an important biological role of DNAJB1 in 
neurodegenerative diseases (Zijlstra et al. 2010). 
 
 
3.1.2 Autophagy System 
Autophagy is a crucial multi-step pathway that allows the cell to eliminate 
misfolded and aggregated proteins, dysfunctional organelles or pathogens 
(Dunn 1990, Noda et al. 2002, Shintani et al. 2004, Yu et al. 2018). Autophagy 
is responsible for the degradation of multiple cargos, such as protein 
aggregates (aggrephagy), mitochondria (mitophagy), lipid droplets (lipophagy), 
ER (ERphagy), ribosomes (ribophagy), proteasomes (proteophagy) or bacteria 
(xenophagy) (Rogov et al. 2014). 
The initial observations of autophagic events were detected in morphological 
studies in rat liver cells (De Duve et al. 1955). The autophagy genes were 
identified in yeast, and it was demonstrated that autophagy is a conserved 
pathway across various organisms (Tsukada et al. 1993, Klionsky et al. 2003, 
Meijer et al. 2007). It was found that this multi-step pathway involves the 
degradation of cytoplasmic material by the lysosome.  
There are three major types of autophagy that have distinct cargo delivery 
mechanisms to the lysosome: chaperone-mediated autophagy (CMA), micro-
autophagy and macro-autophagy. While in CMA (only in mammalians) the 
import of misfolded proteins into the lysosome is assisted by lysosomal 
membrane proteins (including chaperones) (Agarraberes et al. 2001, Cuervo et 
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al. 2014), in micro-autophagy, the lysosome membrane directly engulfs a part of 
the cytoplasm (Li et al. 2012). 
The macro-autophagy (thereafter “autophagy”) is the main autophagic pathway 
(Figure 1.3). It is regulated by mTOR and AMPK signaling and can be triggered 
e.g. by amino acid starvation (induction) promoting the formation of a double 
vesicle (nucleation) that surrounds a fraction of the cytosol (Figure 1.3) (Kim et 
al. 2011). Next, the vesicle elongates and forms an autophagosome 
(elongation). The autophagosome then fuses with a lysosome (maturation) 
leading to the degradation of all sequestered components (substrate breakdown) 
(Lawrence et al. 1992, Mizushima et al. 1998, Yu et al. 2018). Autophagy relies 
on the recognition of cargos by an autophagic adaptor, SQST-1/p62 or NBR-1 
that binds to LC3-II (LGG-1 in C. elegans), which allows the engulfment of the 
non-functional cellular components (Figure 1.3) (Kabeya et al. 2000, Johansen 
et al. 2011).  
The autophagy pathway is an essential cell survival mechanism, and an 
impaired autophagic flux is associated with diverse diseases such as cancer, 
infectious diseases or neurodegeneration (Shintani et al. 2004, Codogno et al. 
2005, Wong et al. 2010, Jiang et al. 2014, Mizumura et al. 2014). It has been 
shown that neurodegenerative disease models display a dysfunctional 
autophagic process, despite the fact that disease-associated proteins such as 
amyloid-beta (Aβ, Alzheimer’s disease) or mutant Huntingtin (mHtt, 
Huntington’s disease) can be eliminated by autophagy (Ravikumar et al. 2002, 
Webb et al. 2003, Yu et al. 2004, Iwata et al. 2005), (Winslow et al. 2010, Nixon 







Figure 1. 3 - The multi-step autophagy pathway. 
Upon autophagy induction, a double membrane vesicle elongates and engulfs non-
functional cellular cargos. The formed vesicle, autophagosome, fuses with the 
lysosome, leading to the degradation of all encapsulated material. Autophagy adaptors 
such as the SQST-1/p62 assist the elimination of ubiquitinated cargos, due to its 
binding to LC3/LGG-1, which is an essential autophagic membrane protein. 
 
 
3.1.3 Ubiquitin-Proteasome System 
The Ubiquitin-Proteasome System (UPS) is the main responsible pathway for 
the degradation of misfolded proteins (Goldberg 2003, Amm et al. 2014). 
Substrates for the UPS are poly-ubiquitinated via a cascade reaction conducted 
by E1, E2 and E3 ligases (Figure 1.4). Subsequently, the ubiquitinated proteins 
are targeted, unfolded and degraded by the 26S proteasome in an energy-
dependent process (Hershko et al. 1980). The formation of specific poly-
ubiquitin linkages allows the substrate recognition by the 19S regulatory particle 
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(RP) and subsequent degradation by the 20S core particle (CP) into small 
peptides (Figure 1.4).  
The UPS is a key component of the proteostasis network, and its function is 
indispensable for the efficient removal of toxic proteins (Bhattacharyya et al. 
2014, Collins et al. 2017). Proteasome dysfunctions have been linked to many 
diseases such as cancer, autoimmune, and neurodegenerative diseases (Paul 
2008, Schmidt et al. 2014). It has been shown that proteins associated with 
neurodegenerative diseases can impair proteasome function (Ciechanover et al. 
2003, Paul 2008, Zheng et al. 2016). Interestingly, proteasomes have the ability 
to degrade disease-related proteins such as the N-terminal fragment of mHtt 
(Juenemann et al. 2013). Despite this observation, the poly-ubiquitin tagging 
and the degradation rates are not sufficient to prevent an accumulation of 
aggregated mHtt that ultimately leads to proteasome dysfunction (Bence et al. 




Figure 1. 4 - Degradation of misfolded proteins by the UPS. 
Misfolded proteins are tagged with ubiquitin in a cascade reaction conducted by E1, E2 
and E3 enzymes. E1 ubiquitin-activating enzymes bind and transfer ubiquitin to E2 
ubiquitin-conjugating enzymes, and together with E3 ligases, transfer ubiquitin to the 
misfolded protein. The poly-ubiquitinated proteins are recognized and unfolded by the 
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proteasome lid (19S, regulatory particle) and then degraded in the core of the 
proteasome (20S, core particle) into small peptides.   
 
 
3.2 C. elegans as a model organism 
C. elegans is a transparent, free-living and non-parasitic nematode that exists in 
two sexes, hermaphrodites and males (Brenner 1974). Its genome was fully 
sequenced in 1998 and revealed that the 100 million base pairs encode for 
more than 19.000 genes (Consortium 1998). The nematode’s genome is spread 
in six pairs of chromosomes (five autosomes and one sex). The number of the 
X chromosomes determines the sex. While hermaphrodites have a paired X sex 
chromosome, XX, males have only one X chromosome, X0. The incidence of 
males in a population is rare, and they account for only 0.1% of the population 
under normal growth conditions (Brenner 1974).  
The nematodes have an exact cell number (hermaphrodites – 959, and males – 
1031). Its tubular body is composed of distinct tissues, like muscle, neurons, 
intestine, excretory system, gonads, glands, and a hypodermis. The 
neuromuscular pharynx in its head region is responsible for food uptake 
(transferring food into the intestine) and the pumping rate can be used as 
readout for organismal fitness (Sulston et al. 1977, Altun 2017). 
C. elegans has a short life cycle as it takes only 3.5 days (at 20°C) for an egg to 
develop into an egg-laying adult (Figure 2.1) (Brenner 1974). After egg 
development, animals hatch as larvae state 1 (L1) and mature through three 
additional larvae stages (L2, 3 and 4) until they reach adulthood. At 20°C, 
hermaphrodites lay approximately 300 eggs and live around two to three weeks 
reaching the maximum of 1 mm in length and 80 μm in diameter (Brenner 1974, 
Markaki et al. 2010). If L1 stage animals face starvation conditions or other 
stresses such as heat, they can enter into a dauer state and survive many 
months without access to food. When food is available, dauer larvae normally 
develop to L4 and adult animals (Byerly et al. 1976, Altun 2017).  
C. elegans was first described as a model organism by Sidney Brenner in 1974 
(Brenner 1974). In the laboratory, animals can be grown on agar plates or in 
liquid cultures supplied with bacteria as food source (Markaki et al. 2010). C. 
Introduction 
15 
elegans has been successfully employed as an animal model due to some 
attractive features such as a short lifespan, transparent body, known cell 
lineage and easy maintenance. In addition, the fact that approximately 80% of 
the nematode’s proteome have a human ortholog, and the ability of genetically 
modifying the animals, for instance by depleting genes via RNA interference 
(RNAi), turned C. elegans into a powerful tool to study many disciplines such as 
developmental biology, cell biology or neurobiology (Lai et al. 2000, Hariharan 








The population of C. elegans is composed of hermaphrodites (99.9%) and males 
(0.1%). The development of C. elegans from egg to egg-laying adult involves many 
steps. Eggs mature into different stages and hatch as larvae stage 1 (L1). In normal 
condition, the L1 animals grow and enter three subsequent developmental stages (L2, 
3 and 4), and reach adulthood (capable of laying eggs) after approximately 3.5 days. If 
L1 nematodes have no access to food, animals will arrest. Also, if L1 stage animals are 
exposed to stress conditions (e.g. heat stress or limited food), they can enter a dauer 
stage and survive several months. Dauer stage nematodes can develop normally into 
L4 and adult stages if growth conditions improve. 
The temperature influences the life cycle of C. elegans in a time-wise manner, as the 
development from egg to egg-laying adult can take 90 h or 47 h if animals grow at 
15°C or 20°C, respectively.   
 
 
3.2.1 C. elegans as a model to study aging 
A collapse in many cellular pathways is linked to the progression of aging. With 
the progression of aging, organisms are less capable of keeping a balanced 
cellular environment, and failure in maintaining proteostasis increases the 
protein misfolding and aggregation propensity (Naidoo et al. 2008, Ben-Zvi et al. 
2009).  
C. elegans is a suitable animal model for aging studies due to its short lifespan 
of about two to three weeks. It has been shown that while the age advances, 
the load of misfolded and aggregated proteins increase (David et al. 2010). In 
fact, around one-third of the proteome changes its abundance in old animals. 
An example of this are the ribosomal proteins, which decline in its abundance 
and lead to a decline in protein synthesis upon aging (Walther et al. 2015).  
The modulation of signaling pathways such as the insulin pathway has revealed 
that aging is a programmed process that can be delayed (Greer et al. 2008). 
Mutants of the insulin pathway mutants, such as daf-2 (insulin receptor) and 
age-1 (catalytic subunit of PI3K) knockouts are long-lived (Friedman et al. 1988, 
Kenyon et al. 1993, Dorman et al. 1995). Both mutations in the insulin pathway 
lead to the activation of the transcription factor DAF-16, which induces the 
expression of numerous antioxidant, antimicrobial or chaperone genes 
(Mukhopadhyay et al. 2006). DAF-16 is the ortholog of the human FOXO3A, 
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which is associated with longevity in humans as well (Willcox et al. 2008). 
Besides the long-lived phenotype, these mutants are more resistant to heat, 
oxidative stress, and bacterial infection, demonstrating the important role of the 
insulin pathway for the organismal health (Lithgow et al. 1995, Honda et al. 
1999, Garsin et al. 2003). 
In addition to a proteostasis collapse discussed above, a number of different 
mechanisms have been proposed to explain the aging process, such as the 
telomere shortening, DNA/mitochondria damage, or cellular senescence 
(Harman 1956, Levy et al. 1992, Bhatia-Dey et al. 2016). While the telomere 
theory proposes that the shortening of telomeres after every cell division is the 
cause of aging, the mitochondria damage theory (known as “The free radical 
theory of aging”) explains the aging process with the accumulation of reactive 
oxygen species that damage DNA, mitochondria, proteins, and lipids. The free 
radical theory of aging has produced some controversy, as it has been shown 
that both C. elegans and mice Mclk1 mutants (mitochondrial enzyme) exhibit 
increased oxidative stress, yet they live longer than wt (Wong et al. 1995, Liu et 
al. 2005, Lapointe et al. 2008, Lapointe et al. 2009). Both telomere shortening 
and mitochondria damage can trigger cellular senescence (Di Micco et al. 2008, 
Bernadotte et al. 2016, Venkatachalam et al. 2017). The cellular senescence 
theory of aging states that aging is caused by an abnormal accumulation of 
senescent cells (cells that no longer divide), which consequently perturbs the 
physiology of multiple tissues (Bhatia-Dey et al. 2016, Ogrodnik et al. 2017). 
Individually, the proposed theories do not entirely explain the process of aging 
and yet their arguments are not mutually exclusive. Aging is a complex process 
and may be caused or at least affected by a number of cellular signaling 
pathways or external factors.   
 
 
3.2.1.1 Neurodegenerative diseases 
The life expectancy for humans is continuously rising, and reports from the 
United Nations and World Health Organization predict that in 2050 the number 
of elderly people will have more than tripled in 2050 (WHO 2010, United 
Nations 2015). The increase of the human lifespan is associated with a higher 
Introduction 
18 
prevalence of diseases such as cancer, cardiovascular diseases or 
neurodegenerative diseases (Niccoli et al. 2012).  
 
Alzheimer’s disease 
Alzheimer’s disease (AD) is a devastating form of dementia that affects 25-50% 
of individuals that are older than 85 years (Duthey 2013). AD patients display 
severe memory loss and cognitive decline due to reduced brain mass in regions 
like the hippocampus (Schuff et al. 2009, Padurariu et al. 2012). The pathology 
is linked to mutations and post-translational modifications, and one of the 
hallmarks of AD is the accumulation of extracellular plaques and neurofibrillary 
tangles that contain Aβ and tau protein, respectively (Bloom 2014). Aβ peptides 
result from the cleavage of the amyloid precursor protein (APP), a 
transmembrane protein. APP cleavage by β- and γ-secretases generates 
fragments of 36 to 43 amino acids (Marsden et al. 2011). Despite the important 
role of the APP in the formation and function of synapses, its processing 
produces neurotoxic peptides such as Aβ1-42/40 found in plaques in post-mortem 
AD brains (Milward et al. 1992, Klein et al. 1999, Torroja et al. 1999).  
C. elegans has been employed to study AD by expressing Aβ in the muscle or 
neuronal cells (Figures 2.2 A+B). It has been shown that Aβ accumulation is 
associated with proteotoxicity that manifests in a reduced lifespan and early 
onset of paralysis (Link 1995, Link et al. 2003).  
 
Polyglutamine diseases 
The abnormal repetition of the aa CAG (above 35 repeats) in specific proteins is 
associated with nine neurodegenerative diseases like spinocerebellar ataxias, 
Machado-Joseph’s disease, dentatorubral-pallidoluysian atrophy or 
Huntington’s disease (HD) (Ikeda et al. 1996, Suzuki et al. 2010, Seidel et al. 
2016).  
HD is characterized by the extension of the polyQ region in the Htt protein. Htt 
protein is known to be involved in brain development and vesicular transport 
(e.g. synaptic, endosomal or autophagic) (Reiner et al. 2003, Cattaneo et al. 
2005, Schulte et al. 2011). However, Htt aggregates and accumulates when the 
polyQ region is expanded, causing neuronal loss in the cerebral cortex 
(Goldberg et al. 1994, Gusella et al. 1998). The number of polyQ repeats is 
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directly associated with a stronger Htt aggregation and the severity of the 
symptoms, and inversely correlated with the age of disease onset (Andrew et al. 
1993, Snell et al. 1993).  
In nematodes expressing polyQ in muscle or neuronal cells (Figures 2.2 A+B), it 
has been shown that an increase of polyQ repetitions correlates with higher 




Figure 2. 2 - C. elegans as a model for neurodegenerative diseases. 
Expression of an aggregation-prone protein involved in Alzheimer (Aβ) and 
Huntington’s disease (polyQ) in the neuronal and muscle cells of C. elegans. 
 
 
3.3 Aims of the study 
A tight regulation and cooperation of the different proteostasis network 
components is critical to preserving a healthy cellular environment (Morimoto et 
al. 2014). Failure in PN pathways leads to an accumulation of protein 
aggregates, and is associated with aging and disease (Hipp et al. 2014, 
Kaushik et al. 2015). Protein misfolding and aggregation can be remodeled by 
the action of chaperones, UPS and autophagy (Wolff et al. 2014, Diaz-
B     Neurons
A     Muscle
Aggregate
Alzheimer and Huntington’s disease models
Aβ and PolyQ expression
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Villanueva et al. 2015). However, it remains unclear how these three 
proteostasis mechanisms are regulated and coordinated on an organismal level 
with the progression of aging and in disease. In this thesis, I aimed to unravel 
the crosstalk between the chaperones that constitute the HSP110/70/J 
disaggregation complex with the autophagy and proteasome systems in C. 
elegans and HEK293 cells. In addition, the autophagy and proteasome 
functions were investigated during aging and in neurodegenerative disease 
models. 
To understand how these three proteostasis mechanisms are coordinated, the 
following questions were addressed: 
 
I. Can the protein clearance machinery compensate for a loss of 
HSP110/70/J complex members? 
II. What is the impact of aging and disease on autophagy and proteasome 
pathways? 
III. How do aging and loss of chaperone-mediated disaggregation capacity 
affect autophagy and proteasome? 





4 Results  
4.1 Impact of proteostasis imbalances on autophagy and proteasome 
pathways 
Cells are equipped with a powerful proteostasis network comprised of molecular 
chaperones and proteases to cope with proteotoxic stress and maintain a 
functional proteome (Kim et al. 2013, Labbadia et al. 2015). While autophagy 
and UPS are responsible for the elimination of non-functional cellular 
components, chaperones ensure the native state of proteins by assisting e.g. 
de novo folding and protein refolding. Furthermore, the HSP110/70/J chaperone 
complex can also prevent and reverse protein aggregation. These protein 
quality control mechanisms are key in maintaining proteostasis.  
To understand the impact of the loss of disaggregation capacity on the 
maintenance of proteostasis, and in particular, on the clearance of protein 
aggregates, chaperones from the HSP110/70/J complex were depleted in C. 
elegans and HEK293 cells. The selection of the distinct members of the 
HSP/110/70/J complex was based on the following criteria: A) conservation 
from nematode to human and B) known involvement in protein disaggregation 
(Table 1).  
The selected human and C. elegans J-proteins, together with HSP110/70 
chaperones, can disaggregate amorphous (e.g. luciferase) and amyloid 
aggregates (α-syn and mHtt) (Rampelt et al. 2012, Gao et al. 2015, Nillegoda et 
al. 2015, Scior et al. 2018). The disaggregase complex requires three 
chaperones to be active: Hsp70 (substrate binding and folding), HSP110 
(nucleotide exchange factor), and J-protein(s) (substrate recognition, targeting 
and activation of Hsp70). 
The J-proteins act as an Hsp70 co-chaperones, and play a key role in the 
recognition of multiple substrates, and consequently in the composition of the 
disaggregation complex. Therefore, the composition of the chaperone complex 
can vary in response to different stress, substrates or aging. In case of amyloids, 
the disaggregation can be achieved with the involvement of a single type II J-
protein, as shown for α-syn and mHtt, where the disaggregation is performed by 
HSP-70, HSP-110 and DNAJB1 (Gao et al. 2015, Scior et al. 2018). However, 
the disaggregation of amorphous aggregates is accelerated when members of 
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type I and II J-proteins are present. This phenomenon was demonstrated for 
luciferase, where the combination of HSP-70/HSP-110 with both, DNJ-12 and 
DNJ-13 exerts a synergistic effect and a more powerful disaggregation 
(Rampelt et al. 2012, Nillegoda et al. 2015). For this reason, and due to the 
diversity of the J-protein family, the depletion of three different J-proteins (two 
type-I and one type-II) that display the most robust disaggregation activity was 
employed.  
 
Table 1 - Overview of the chaperones analyzed in this study. 
Chaperone protein Biological role 
Human C. elegans Identity* Family Disaggregation Substrate 
HSPA8 HSP-1 86% Hsp70 
Substrate binding; 
Protein folding 
Luciferase (Rampelt et al. 
2012, Nillegoda et al. 
2015), α-syn (Gao et al. 
2015), mHtt (Scior et al. 
2018) 
HSPA4 HSP-110 44% Hsp70 
Nucleotide 
exchange factor 
Luciferase (Rampelt et al. 
2012, Nillegoda et al. 
2015), α-syn (Gao et al. 
2015), mHtt (Scior et al. 
2018) 






Luciferase (Rampelt et al. 
2012, Nillegoda et al. 
2015), α-syn (Gao et al. 
2015) 






Luciferase (Rampelt et al. 
2012, Nillegoda et al. 
2015), α-syn (Gao et al. 
2015), mHtt (Scior et al. 
2018) 






Luciferase (Rampelt et al. 





The following genes were depleted in C. elegans: hsp-1 (Hsc70), hsp-110 and 
the J-protein encoding genes dnj-12, dnj-13 and dnj-19; and the respective 
mammalian orthologous genes in HEK293 cells: hspa8, hspa4, dnaja1, dnajb1 
and dnaja2. As shown in figure 3.1, the knockdown efficiencies were analyzed 
and revealed remaining chaperone protein levels of 20-40% in C. elegans, and 





Figure 3. 1 - Analysis of RNAi and siRNA chaperone knockdown efficiencies in C. 
elegans and HEK293 cells. 
A) Western blot analysis of chaperone levels of day 4 nematodes treated with RNAi 
against the indicated chaperones. B) Chaperone levels in HEK293 cells, which were 
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elegans chaperone was normalized to α-tubulin levels and then to control RNAi (A). D) 
The relative band intensity of each mammalian chaperone was normalized to α-tubulin 
levels and then to control siRNA (B). The molecular weight is indicated on the left.  
 
Based on the crucial role of the HSP/110/70/J chaperone complex, I 
hypothesized that the loss of disaggregase capacity would be likely to cause an 
accumulation of misfolded and aggregated proteins, which subsequently could 
trigger a compensatory activation of A) autophagy system and B) ubiquitin-
proteasome system (Figure 3.2).  
In the following sections, the responses of autophagy and proteasome 




Figure 3. 2 - Analysis of the clearance machinery upon HSP110/70J complex 
members knockdown. 
A) Autophagy and proteasome (B) pathways were investigated upon depletion of 
chaperones genes that constitute the disaggregation complex.  
 
 
4.2 Autophagy response to proteostasis perturbations 
4.2.1 Autophagy is induced when chaperone disaggregase capacity is 
compromised 
In order to study the autophagy pathway, I used a well-established autophagy 
reporter strain (DA2123) that encodes the LGG-1 protein tagged with GFP 
expressed ubiquitously in the animal (Melendez et al. 2003). This reporter 
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enables the visualization of autophagic structures by light microscopy (Kang et 
al. 2007, Zhang et al. 2015).  
Chaperones of the disaggregase complex were depleted in the DA2123 
animals, and the GFP::LGG-1 expression pattern was analyzed on day 6 
(Figure 3.3 A). Animals treated with control RNAi display a low basal level of 
autophagic vesicles in the head and intestine. Depletion of the chaperones led 
to a pronounced accumulation of autophagosomal structures mainly in the 
intestine. This accumulation was more prominent when animals were treated 
with RNAi during 6 days. Indeed, the increased number of GFP::LGG-1 positive 
structures detected by confocal microscopy was due to an increase of 
GFP::LGG-1 protein levels confirmed by western blot, using an anti-GFP 
antibody (Figures 3.3 B+C).  
 
 














































































































































































A) Fluorescent images of DA2123 (GFP::LGG-1) animals (day 6) that were subjected 
to RNAi treatment to deplete hsp-1, hsp-110, dnj-12, dnj-13, and dnj-19. The empty 
vector L4440 served as control. The upper panel shows the head/intestinal region of 
the animals and the lower panel is a magnification of the indicated regions of the upper 
panel. Scale bars: 50 μm (upper panel) and 5 μm (lower panel). B+C) Immunoblotting 
of lysates of DA2123 animals (day 6) treated with RNAi against the indicated genes. 
The relative band intensities of GFP::LGG-1 (anti-GFP) were normalized to the α-
tubulin levels and then to control RNAi. The error bars represent the standard deviation 
from a minimum of four independent experiments.  
 
 
To assess the endogenous levels of LGG-1 and to avoid the potential negative 
effects of the GFP fusion, an anti-LGG-1 antibody was generated. The 
specificity for LGG-1 was confirmed using a lgg-1 knockdown that led to a 
reduction in the respective protein levels. (Figures 3.4 A+B). Moreover, bec-1 
RNAi led to an accumulation of LGG-1 protein due to autophagy blockage. The 
LGG-1 antibody detected the total amount of LGG-1 and consequently the 
levels of LGG-1-I/II could not be differentiated.  
 
 
Figure 3. 4 - LGG-1 and SQST-1/p62 levels upon genetic modulations.  
A-B) LGG-1 levels from day 4 wt animals treated with the indicated RNAi. The LGG-1 
levels were normalized to α-tubulin levels and then to RNAi control (B). C-D) SQST-
1/p62 levels from day 4 wt animals treated with the indicated RNAi. Some lanes were 
removed from the immunoblot as indicated by the dashed line (C). SQST-1/p62 levels 





















































































































































































Using this antibody, I found that endogenous LGG-1 protein also accumulates 
in response to knockdown of the chaperone genes encoding the HSP110/70/J 
complex members and thus confirm the data obtained using the GFP::LGG-1 
reporter (Figures 3.5 A+B). An accumulation of LGG-1 could be interpreted 
either as induction or impairment of autophagy, as both scenarios lead to an 
increase of LGG-1 protein levels. Therefore, it is critical to evaluate different 
autophagy markers to access the autophagic flux correctly. 
In order to differentiate between these two possibilities, the levels of SQST-
1/p62 were analyzed. SQST-1/p62 is an ubiquitin-binding protein that acts as 
an adaptor for the autophagy pathway, and is also degraded by autophagy, 
thus its levels can indicate the state of the autophagic flux (Bjorkoy et al. 2005). 
An SQST-1/p62 antibody was generated, and confirmed that the produced 
antibody recognizes the SQST-1/p62 protein (Figure 3.4 C+D). The levels of 
SQST-1/p62 were evaluated upon chaperone knockdown (Figure 3.5 A+C). 
Chaperone depletion, especially of hsp-1 and hsp-110, led to a reduction of 
SQST-1/p62 levels when compared to the control condition, which indicates an 
increased autophagic flux.  
The increase of LGG-1 and simultaneous decrease of SQST-1/p62 protein, 
suggests that the depletion of chaperones required for disaggregase activity in 






Figure 3. 5 - LGG-1 and SQST-1 protein levels upon RNAi-mediated knockdown 
of HSP110/70/J complex members. 
A) LGG-1 and SQST-1/p62 protein levels from wt animals (day 6) treated with RNAi 
against the indicated chaperones. The LGG-1 (B) and SQST-1/p62 (C) levels were 
normalized to α-tubulin and then to control RNAi. The error bars represent the standard 
deviation of a minimum of three independent experiments. 
 
 
To verify the relevance of these findings in a mammalian system, the 
autophagic flux was analyzed upon siRNA treatment of the orthologous 
chaperones in HEK293 cells. Analogously to the C. elegans data, chaperone 
depletion led to an increase of LC3-II protein levels (LGG-1 homolog) in 
HEK293 cells (Figures 3.6 A+B). LC3 levels are a well-established reporter of 











































































































































































































































(Kabeya et al. 2000, Mizushima et al. 2010). Nevertheless, a distinction 
between induction and impairment of autophagic flux is required. In order to 
accurately differentiate between those two scenarios, cells were treated with 
Bafilomycin A1 (BafA1). BafA1 is a lysosome V-ATPase inhibitor that inhibits 
the autophagic flux and therefore unravels changes in autophagosome 
synthesis (Tanida et al. 2005, Fass et al. 2006). In the absence of BafA1, LC3-II 
levels are elevated upon knockdown of the chaperone genes, and the presence 
of BafA1 caused an increase of LC3-II levels compared to the siRNA control 
(Figures 3.6 A+B). The elevated LC3-II levels upon BafA1 treatment indicate an 
































































































































































































































































































Figure 3. 6 - LC3 levels in HEK293 cells upon HSP110/70/J siRNA and 
Bafilomycin treatment. 
A) Immunoblotting of HEK293 cells lysates, which were transfected with the respective 
chaperone siRNA. Cells were additionally treated with 200 nM Bafilomycin A1 4 h 
before harvest and lysis. The LC3-II levels were normalized to α-tubulin levels and then 




4.2.2 Autophagy is impaired in old animals and less responsive to 
chaperone depletion  
With the progression of aging, misfolded and aggregated proteins accumulate 
and pose a burden to the PN. These aggregates are potential substrates for 
either remodeling by the disaggregation complex, or clearance by the 
proteasome or autophagic pathway. The analysis of the autophagy flux during 
aging has produced contradictory outcomes. While some laboratories have 
reported autophagy activation during aging (Chapin et al. 2015), others have 
suggested the opposite (Chang et al. 2017). The conflicting data could be due 
to different animal models and experimental conditions. I decided to take 
advantage of the short lifespan of C. elegans to investigate how autophagy is 
regulated with the progression of aging in the nematode.  
In order to measure the autophagic flux over aging, the levels of LGG-1 and 
SQST-1/p62 were analyzed in animals of 4 (young), 6, 8 and 10 (old) days of 
life. As presented in figures 3.7 A+B, LGG-1, and SQST-1/p62 levels increase 
from young to old animals. This data strongly suggests an impairment of 
autophagy with the progression of aging, and it is in agreement with previous 






Figure 3. 7 – Autophagic flux with the progression of aging. 
A) LGG-1 and SQST-1/p62 levels were determined in nematodes of 4, 6, 8 and 10 
days of life. The LGG-1 and SQST-1/p62 levels were normalized to α-tubulin levels and 




Taking this data into account, I wondered how autophagy is regulated during 
aging upon depletion of the disaggregating chaperones. To address this 
question, I compared the autophagy flux upon knockdown of the HSP110/70/J 
complex members between young and old animals. The analysis of the 
autophagy reporter GFP::LGG-1 revealed an accumulation of LGG-1 positive 
structures in old animals (day 10) when compared to young animals (day 4), in 
the control condition (Figure 3.8). The higher LGG-1 protein levels in old 
animals presented in figure 3.7, supports the accumulation of LGG-1 positive 
structures in aged animals at day 10. An accumulation of LGG-1 positive 
structures in old animals was detected in all RNAi conditions including the 
control. Thus, the increase of LGG-1 positive structures detected in young 
animals upon chaperone knockdown compared to the control (Figure 3.3 A - 










































































Figure 3. 8 – Analysis of GFP::LGG-1 fluorescence after chaperone RNAi on days 
4 and 10.  
DA2123 animals were subjected to RNAi treatment against the indicated genes. The 
fluorescent images are a magnification of the intestinal region and were acquired at 
day 4 (upper panel) and day 10 (lower panel). Scale bars: 5 μm. 
 
 
These results imply that autophagy may be less responsive to chaperone 
depletion with the progression of aging. To analyze the autophagic flux, SQST-
1/p62 and LGG-1 protein levels were assessed upon chaperone knockdown in 
a time-course experiment (day 4, 6, 8 and 10). As demonstrated in figures 3.9 
A+B, LGG-1 protein levels peak for all distinct knockdowns at day 6, and SQST-
1/p62 correspondingly exhibits the lowest levels between days 4 and 6. As 
aging progresses (day 6 to day 10), autophagy appears to be less activated in 
response to chaperone depletion. Nearly no differences can be observed in 
LGG-1 and SQST-1/p62 levels between control and the chaperone knockdowns. 
In order to analyze if the changes detected in the protein levels were associated 
with transcriptional regulation, the mRNA levels of lgg-1 were analyzed upon 
hsp-1, hsp-110 and dnj-13 knockdown by qRT-PCR. As shown in figure 3.9 C, 
lgg-1 mRNA levels are elevated only in young animals (days 4 and 6), indicating 
activation of autophagy at young age. No significant changes to the control 
were observed in older animals (day 10). The analysis of sqst-1/p62 mRNA 
































This data suggests an induction of autophagy in young animals in response to 
the loss of HSP110/70/J complex members. However, in old animals autophagy 




Figure 3. 9 - Analysis of protein and mRNA levels of LGG-1 and SQST-1/p62 upon 
chaperone depletion during aging. 
A-B) The levels of LGG-1 and SQST-1/p62 were measured at day 4, 6, 8 and 10 of wt 
animals treated with RNAi against the indicated chaperones. The LGG-1 and SQST-
1/p62 levels were normalized to α-tubulin levels and then to RNAi control. These 
graphs represent the average values from a minimum of two independent experiments 
(error bars were excluded for clarity). C) lgg-1 mRNA levels from day 4, 6 and 10 
animals treated with the indicated RNAi. The values were normalized to the control 








































































































































4.2.3 Chaperone knockdown reduces lysosomal pool in C. elegans 
To comprehensively understand how chaperone depletion affects autophagy, I 
analyzed the lysosomal function upon HSP110/70/J complex members 
knockdown. 
The fusion between autophagosomes and lysosomes (Figure 1.3) is a crucial 
step in autophagy pathway, and it is dependent on the transport of both 
structures (Dunn 1990, Tooze et al. 1990, Lawrence et al. 1992, Berg et al. 
1998, Fader et al. 2008). Therefore, the vesicular transport is essential for the 
autophagic flux (Longatti et al. 2009, Tooze et al. 2010). RAB proteins 
participate in vesicular trafficking, and RAB-7 is known to be involved in late-
endosomal trafficking. RAB-7 assists in the maturation of autophagosomal 
structures by interacting with LMP-1 (Gutierrez et al. 2004, Lin et al. 2011). 
Upon maturation of autophagosomal structures a new vesicle, 
autophagolysosome, is formed and subsequently degraded. Thus, the 
lysosomal pool is affected by the autophagic flux and can be used as a read-out 
for either an impairment (accumulation of lysosomes) or activation of autophagy 
(decrease of lysosomes) (Yu et al. 2010). The lysosome pool can be quantified 
with LysoTracker, which is a fluorophore linked to a weak base that is highly 
selective for acidic organelles (Chen et al. 2015). The lysosomes have a pH 
between 4.5 and 5, which allows the accumulation and protonation of the 
fluorophore that subsequently leads to the emission of fluorescence.  
The analysis of the lysosome pool was performed by assessing: A) the levels of 
LMP-1 in animals expressing LMP-1::GFP and the levels of RAB-7 in animals 
expressing RAB-7::GFP as well as B) the lysosomal abundance by 








Figure 3. 10 – Lysosome function analysis. 
A) LMP-1 is a lysosomal (L) membrane protein, which interacts with the vesicular 
transporter RAB-7 in order to fuse with autophagosomes. B) LysoTracker-Red 
accumulates within the lysosomes and its fluorescence allows the quantification of the 
lysosome pool.  
 
 
To understand how these three lysosomal reporters (LysoTracker, RAB-7, and 
LMP-1) reflect changes in autophagy flux, animals were treated with established 
autophagy chemical modulators that either activate (rapamycin) or impair (3-
Methyladenine (3-MA) and chloroquine (CQ)) the autophagic flux. While 
rapamycin strongly binds and inhibits mTOR leading to activation of autophagy, 
3-MA impairs autophagy by inhibiting PI3K, which controls mTOR activation 
(Seglen et al. 1982, Noda et al. 1998). CQ accumulates in the lysosome and 
alters its acidification (Seglen et al. 1979). The increase of pH inhibits lysosomal 
enzymes and subsequently leads to autophagy impairment.  
Activation (rapamycin) and impairment (3-MA or CQ) of autophagy led to a 
reduction and increase of the lysosome pool, respectively, detected by 
LysoTracker-Red staining (Figures 3.11 A+B). As shown in figures 3.11 E+F, 
RAB-7::GFP levels increased when autophagy was activated and were not 
affected upon inhibition of autophagy. LMP-1::GFP reporter did not exhibit a 
robust response to autophagy modulation (Figures 3.11 C+D). Therefore, 
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LysoTracker-Red staining was applied to accurately assess the lysosome pool 




Figure 3. 11 - Modulation of the autophagy pathway.  
A-B) Lysosomal pool of day 4 old animals treated with 200 μM Rapamycin, 10 mM 3-
Methyladenine or 10 mM chloroquine for 20 h was stained with LysoTracker-Red and 
then imaged using a fluorescent microscope. LysoTracker-Red fluorescence was 
quantified and normalized to control animals (B). The error bars represent the standard 
deviation of 4-10 animals. Scale bar: 200 μm. C-D) Fluorescent imaging of day 4 LMP-
1::GFP expressing animals treated with 200 μM Rapamycin, 10 mM 3-Methyladenine 
or 10 mM chloroquine for 20 h. GFP fluorescence was quantified and normalized to 
control animals (D). The error bars represent the standard deviation of 4-5 animals. 
Scale bar: 200 μm. E-F) Day 4 RAB-7::GFP expressing nematodes were imaged after 
20 h of 200 μM Rapamycin, 10 mM 3-Methyladenine or 10 mM chloroquine treatment. 
The upper panel shows the intestinal cells of the nematodes, and the lower panel 
depicts a magnified region of the upper panel (E). GFP fluorescence was quantified 
and normalized to control animals (F). The error bars represent the standard deviation 
of 5-6 animals. Scale bars: 10 μm. 
 
 
Next, the impact of the loss of chaperone disaggregation capacity in the 
lysosome function was analyzed. For that, the lysosomal pool was stained with 
LysoTracker-Red, and as displayed in figures 3.12 A+B, a notable reduction in 
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the lysosome pool stained was detected upon chaperone knockdown when 
compared to the control. The reduction in the lysosome pool supports the 
activation of autophagy upon chaperone depletion depicted in the section 4.2.1, 
which leads to the consumption of the lysosome pool. 
In addition, the effect of chaperone knockdown in the RAB-7::GFP reporter 
strain was investigated. Depletion of genes encoding members of the 
HSP110/70/J complex, led to an accumulation of RAB-7 positive structures in 
intestinal cells, in particular upon knockdown of hsp-110 (Figures 3.12 A+C). 
This result also points to an autophagy activation, as the activation of 
autophagy with rapamycin led to an increase of RAB-7::GFP fluorescence 
(Figures 3.11 E+F). 
Taken together, these results confirm that the autophagy-lysosome pathway is 






Figure 3. 12 - Lysosome pathway response to chaperone knockdown. 
A) Lysosomal pool from day 4 old animals treated with the indicated RNAi was stained 
with LysoTracker-Red and then imaged using a fluorescent microscope (upper panel). 
RAB-7::GFP expressing nematodes were imaged after 4 days of RNAi treatment 
against the indicated genes (lower panel). B) LysoTracker-Red fluorescence was 
quantified and normalized to control RNAi. The error bars represent the standard 
deviation of 10-16 animals. Scale bar: 200 μm. C) RAB-7::GFP fluorescence was 
quantified and normalized to control RNAi. The error bars represent the standard 



















































































































































































































4.2.4 HLH-30 translocates to the nucleus upon chaperone depletion 
Autophagy is tightly controlled on the transcriptional level. In mammals, 
transcriptional regulation of autophagy is controlled by the transcription factor 
EB (TFEB) (Settembre et al. 2011). In C. elegans, the activation of autophagy is 
regulated via HLH-30, a TFEB ortholog (Lapierre et al. 2013).  
To elucidate the mechanism for the activation of autophagy upon depletion of 
chaperones, I employed an HLH-30::GFP reporter strain (Lapierre et al. 2013). 
In normal growth conditions, HLH-30 is mainly localized in the cytoplasm. 
However, upon autophagy activation, it translocates to the nucleus leading to 




Figure 3. 13 - Mechanism of action of the autophagy transcriptional regulator 
TFEB/HLH-30. 
Induction of autophagy leads to TFEB/HLH-30 translocation from the cytosol (C) to the 
nucleus (N), following the expression of autophagy-related genes.  
 
 
This phenomenon can be observed in figure 3.14 A, where the activation of 
autophagy by rapamycin shows a nuclear translocation of HLH-30::GFP. Next, 
chaperones of the disaggregase complex were depleted in the HLH-30::GFP 
reporter strain. Notably, knockdown of hsp-1 (30% of the animals) and hsp-110 
(45%) led to nuclear translocation of HLH-30 (Figures 3.14 B+C). This data 
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suggest that the activation of autophagy upon hsp-1 and hsp-110 depletion is 
regulated via the transcription factor HLH-30. 
 
 
Figure 3. 14 - Translocation of HLH-30 in response to autophagy activation. 
A) Day 4 animals expressing HLH-30::GFP were treated with 200 μM Rapamycin for 
20 h or left untreated (control). The HLH-30::GFP nuclear translocation was analyzed 
in 10 animals. Scale bars: 200 μm (left panel) and 50 μm (right panel, magnification). 
B-C) Animals expressing HLH-30::GFP were subjected to RNAi treatment for 4 days 
before imaging. After image acquisition, the percentage of animals with HLH-30::GFP 
nuclear translocation was determined in 25 animals per condition (C). Scale bars: 200 
μm (upper panel) and 50 μm (lower panel). 
 
 
4.3 Proteasome function upon proteostasis perturbations 
4.3.1 Proteasome capacity is diminished when HSP110/70/J machinery is 
compromised  
The UPS plays a key role in the elimination of misfolded proteins. In this section, 
the UPS capacity in response to depletion of the disaggregating chaperones will 
be characterized.  
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To understand how UPS responds to the depletion of chaperones constituting 
the disaggregase complex, the ex and in vivo UPS capacity of C. elegans and 
HEK293 cells were investigated: A) in vivo – by measuring the degradation 
rates of UbG76V and B) ex vivo – by analyzing the cleavage of Suc-LLVY-AMC 




Figure 4. 1 - Scheme of the analysis of proteasome activity. 
A) The in vivo UPS activity was analyzed by measuring the degradation rates of 
UbG76V. B) The cleavage of the Suc-LLVY-AMC peptide was used to monitor UPS 
activity in protein lysates.  
 
 
As proteasome function has been reported to be regulated in a cell type specific 
manner, I decided to investigate the degradation of a proteasomal substrate in 
different tissues of C. elegans (Hamer et al. 2010). For that, C. elegans 
reporters that express UbG76V::Dendra2 either in the body wall muscle tissue 
(using the unc-54 promoter), or in the GABAergic neurons (using the rgef-1 
promoter) were employed (Figures 4.2 A+B). Dendra2 is a fluorescent protein 
that has been used to study the fate of specific proteins, as it can be irreversibly 
photo-converted from the green to red emission spectrum upon excitation at 
405 nm (Chudakov et al. 2007). In the analyzed reporter lines, Dendra2 is fused 
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to a non-cleavable ubiquitin moiety, UbG76V, which allows the correct poly-
ubiquitination and subsequent targeting of the Dendra2 fusion protein for 
proteasomal degradation (Stack et al. 2000). This sensor is a specific 
proteasomal substrate and enables the quantification of proteasome activity in 
the neuronal and muscle tissue of a whole animal or on a single-cell level by 




Figure 4. 2 – Photo-conversion of UbG76V::Dendra2 in muscle and neurons. 
A) Representative scheme of the photo-conversion of UbG76V::Dendra2 in muscle 
(right panel) and neuronal cells (left panel) of C. elegans. B) Representative 
fluorescent images of photo-conversion of UbG76V::Dendra2 in single muscle (right 
panel) and neuronal cells (left panel) of C. elegans. UbG76V::Dendra2 protein was 






































UbG76V::Dendra2 was developed to be specifically targeted and degraded by 
proteasomes. As can been observed in figure 4.3, depletion of an essential 20S 
proteasome subunit (pas-5) leads to reduced turnover of UbG76V::Dendra2, 




Figure 4. 3 – Degradation rates of UbG76V::Dendra2 upon pas-5 depletion 
Animals expressing UbG76V::Dendra2 in the muscle cells were treated with pas-5 
RNAi for 72 h. UbG76V::Dendra2 protein was converted, and the animals were imaged 
24 h post-conversion. To determine the degradation rates, the fluorescence (561 nm) 
acquired 24 h post-conversion was divided by the fluorescence immediately after 
conversion. The error bars represent the standard deviation of 5-6 animals. 
 
 
Next, chaperones from the disaggregase complex were depleted and the 
degradation rates of UbG76V::Dendra2 were analyzed in muscle and neuronal 
cells. As shown in figure 4.4 A, a pronounced accumulation of photo-converted 
UbG76V::Dendra2 was detected upon depletion of dnj-12 (+27%), dnj-13 
(+17%), and particularly upon hsp-110 (+45%) when compared to the control 
condition 24 h after photo-conversion. In neuronal cells the degradation of 
UbG76V::Dendra2 is much faster, therefore its levels were measured 3 h after 
photo-conversion. Depletion of hsp-1 (+18%) and hsp-110 (+16%) led to a 
slight accumulation of UbG76V::Dendra2 compared to the control in the 


















































This data indicates a reduction of proteasome activity in muscle and neuronal 
cells upon loss of some members of the disaggregase complex, mainly 




Figure 4. 4 - UbG76V::Dendra2 degradation rates in muscle and neurons upon 
chaperone knockdown. 
A-B) Animals expressing UbG76V::Dendra2 in the muscle (YD3) cells (A) or neuronal 
cells (YD12) (B) were treated with RNAi against the indicated genes. 
UbG76V::Dendra2 protein was converted by exposure to 405 nm and imaged 3 
(neurons) or 24 (muscle) hours post-conversion. To determine the degradation rates, 
the fluorescence (at 561 nm) acquired 3 or 24 h after conversion was divided by the 
fluorescence directly after conversion. The error bars represent the standard deviation 
of 9-15 animals. 
 
 
To validate these observations in mammalian cells, a similar experiment in 
HEK293 cells was carried out, where I analyzed the proteasome function upon 
loss of disaggregating chaperones. Cells were transfected with a non-cleavable 
ubiquitin moiety fused to GFP, UbG76V-GFP, (Dantuma et al. 2000) while the 
orthologous chaperone genes were depleted. As a control, cells were treated 
with MG-132. MG-132 is a potent and reversible inhibitor of the proteolytic 









































































































































































































treated with MG-132 showed an accumulation of the proteasome substrate 
UbG76V-GFP (Figures 4.5 A+B). An accumulation of UbG76V-GFP was also 
detected upon hspa4 siRNA (hsp-110 ortholog) (2-fold) (Figures 4.5 A+B), thus 
confirming the data obtained in C. elegans. Moreover, a reduction in the 
degradation rates of UbG76V::GFP upon depletion of hspa8 (hsp-1 ortholog) 
and dnaja1 (dnj-12) was also detected, suggesting that depletion of members of 
the disaggregase complex exert an inhibitory effect on UPS activity in 




Figure 4. 5 – UbG76V-GFP levels upon chaperone depletion in HEK293 cells. 
A) Immunoblotting of lysates of HEK293 cells, which were transfected with the 
respective chaperone siRNA for 48 h and UbG76V-GFP in the subsequent 24 h. As a 
positive control, cells were also treated with 20 μM MG-132 for 4 h. The UbG76V-GFP 
levels were normalized to α-tubulin levels and then to siRNA control (B). The error bars 
represent the standard deviation of three independent experiments. 
 
 
To complement and expand the analysis of the proteasome function, the ex 
vivo proteasome activity was monitored in protein lysates of either complete 
nematodes or HEK293 cells. By taking advantage of a fluorogenic proteasome-
specific substrate, Suc-LLVY-AMC, the chymotrypsin-like proteasome activity 











































































































































































recognized and cleaved by the chymotrypsin-like subunit (β5). Upon cleavage, 
the AMC peptide emits fluorescence that can be monitored. As shown in figures 
4.6 A+B, AMC fluorescence increases over time revealing the proteasome 
activity of wt C. elegans protein lysate. The increase of AMC fluorescence is 
due to proteasome activity as inhibiting the proteasome with MG-132 inhibits 




Figure 4. 6 - Suc-LLVY-AMC cleavage by C. elegans lysate. 
A) Chymotrypsin-like proteasome activity was measured every 5 min of lysates of day 
4 wt nematodes. As a control, 10, 30 and 50 µM MG-132 was incubated with the 




Subsequently, chaperones from the disaggregase complex were depleted, and 
the AMC release was monitored in the lysate of C. elegans and HEK293 cells. 
As depicted in figures 4.7 A+B, animals treated with hsp-110, dnj-12 and dnj-13 
RNAi display a reduction of 20-30% of AMC release over time compared to the 
control indicating a reduction of proteasome capacity. In HEK293 cells, a 
diminished chymotrypsin-like proteasome activity could also be observed upon 
hspa4, dnaja1, dnaja2 and dnajb1 siRNA compared to control condition 
(Figures 4.7 C+D). These observations corroborate the UbG76V data, 
especially for hsp-110/hspa4 depletion that led to a strong decrease of UbG76V 
degradation in C. elegans and HEK293 cells (Figures 4.4 + 4.5).  
wt
10 µM MG-132 
30 µM MG-132 













































































Figure 4. 7 - Proteasome activity of C. elegans and HEK293 cells upon chaperone 
depletion. 
A) Chymotrypsin-like proteasome activity was measured every 5 min in lysates of wt 
nematodes treated with the indicated RNAi for 4 days. The relative activities were 
calculated and normalized to RNAi control (B). The error bars represent the standard 
deviation of three independent experiments. C) Chymotrypsin-like proteasome activity 
was measured every 5 min in lysates of HEK293 cells treated with the indicated siRNA 
for 48 h. The relative activities were calculated and normalized to RNAi control (D). The 

























































































































































































































































































A decrease in the UPS capacities upon chaperone depletion could be either 
due to decreased activities or reduced abundance of the proteasome. An 
analysis of the 20S α-subunit levels would allow differentiating between reduced 
proteasome activity and lower abundance of the proteasomes. Interestingly, 
depletion of hsp-110, dnj-12 and dnj-13 in C. elegans (Figures 4.8 A+B), and 
hspa4, dnaja2 and dnajb1 in HEK293 led to lower levels of 20S α-subunits 
compared to the control condition (Figures 4.8 C+D). The reduction of the 20S 
α-subunit levels correlate with proteasome activity described above and could 





Figure 4. 8 - 20S α-subunits upon chaperone knockdown in C. elegans and 
HEK293 cells. 
A) Relative protein levels of 20S α-subunits of wt animals treated with RNAi against 






















































































































































































































































































































control RNAi (B). The error bars represent the standard deviation of three independent 
experiments. C) Relative protein levels of 20S α-subunits of HEK293 cells treated with 
siRNA against the indicated genes. The 20S levels were normalized to α-tubulin levels 
and then to control siRNA (D). The error bars represent the standard deviation of a 
minimum of six independent experiments. 
 
 
4.3.2 Proteasome function is altered in older animals 
In order to assess how the proteasome capacity is affected with the progression 
of aging, I analyzed first the 20S α-subunit protein levels of nematodes at day 4, 
6, 8 and 10 of life (Figures 4.9 A+B). A strong increase (+63%) in the 20S α-
subunit levels can be observed in old animals (day 10) when compared to 
young animals (day 4). To assess if the increase in 20S levels correlates with 
increased activity, I analyzed the chymotrypsin-like proteasome activity in young 
versus old animals and did not observe a significant difference (Figure 4.9 C). 
This prompted me to study the UPS capacity in different tissues as differences 
between cell types might be masked when analyzing the lysate of the whole 
animal. Thus, I analyzed degradation rates of UbG76V::Dendra2 in muscle and 
neuronal tissue of day 4 and day 7 old nematodes. While muscle cells 
displayed lower levels of converted UbG76V::Dendra2 at day 7 compared to 
day 4 (36% vs. 49%), neuronal cells exhibited higher UbG76V::Dendra2 in old 
animals (48% vs. 34%) (Figure 4.9 D). This data suggests an increase of 
proteasome activity with the progression of aging in muscle cells, yet a 





Figure 4. 9 - Proteasome function with the progression of aging. 
A) 20S α-subunit levels were determined in nematodes of 4, 6, 8 and 10 days of life. 
The 20S levels were normalized to α-tubulin levels and then to day 4 animals (B). The 
error bars represent the standard deviation of five independent experiments. C) 
Chymotrypsin-like proteasome activity was measured in day 4 or 8 old wt nematodes. 
The relative activities were calculated and normalized to day 4. D) The degradation 
rates of UbG76V::Dendra2 animals were measured at day 4 and day 7 of age in 
muscle cells and neuronal cells. UbG76V::Dendra2 protein was converted, and the 
animals were imaged 3 or 24 h after conversion (as in Fig. 4.2). To determine the 
degradation rates, the fluorescence (561 nm) acquired 3 or 24 h after conversion was 
divided by the fluorescence immediately after conversion. The error bars represent the 





To assess how chaperone depletion affects the UPS capacity with the 
progression of aging, I quantified the 20S α-subunit protein levels upon 
chaperone depletion between days 4 and 10 (Figure 4.10 A). As shown above 
(section 4.3.1), 20S α-subunits are reduced in young animals when chaperones 
are depleted. However, in old animals, 20S α-subunits are no longer decreased 
and are now more abundant compared to control when hsp-110, dnj-12, dnj-13, 
and dnj-19 are depleted (days 8 and 10). Taking into account these changes in 
the 20S α-subunits levels, I decided to monitor proteasome activity in older 
animals. As described in the section 4.3.1, the UPS activity is reduced upon 
hsp-110, dnj-12 and dnj-13 RNAi at day 4. Yet, old animals show no significant 
difference to the control in the degradation rates of UbG76V::Dendra2 (muscle 
and neurons) or the cleavage of Suc-LLVY-AMC (Figures 4.10 B+C+D). 
Together, this data shows that aging alters proteasomal levels and activity in a 
tissue-specific manner. In addition, depletion of chaperones does not affect 






Figure 4. 10 - Proteasome levels and activity after chaperone depletion. 
A) The levels of 20S α-subunits were measured at day 4, 6, 8 and 10 of wt animals 
treated with RNAi against the indicated chaperones. The 20S α-subunit levels were 
normalized to α-tubulin levels and then to RNAi control. Depicted is a graph 
representing the average values from a minimum of three independent experiments 
(error bars were excluded for clarity). B-C) The degradation rates of UbG76V::Dendra2 
animals were measured at day 4 and day 7 of age in muscle cells (B) or neuronal cells 
(C). UbG76V::Dendra2 protein was converted, and the animals were imaged 3 or 24 h 
after conversion. To determine the degradation rates, the fluorescence (561 nm) 
acquired 3 or 24 h after conversion was divided by the fluorescence immediately after 
conversion. The error bars represent the standard deviation of 6-16 animals. D) 




































































































































































































































































































































































nematodes treated with the indicated RNAi for 4 or 8 days. The relative activities were 
calculated and normalized to RNAi control in the respective day.  
 
 
4.4 Proteolytic pathways response to hsp-16.41 and hsp-17 depletion 
4.4.1 Autophagy and proteasome pathways are not affected by the loss 
of two small heat shock proteins 
In the sections described above, the impact of the depletion of chaperones from 
the disaggregation complex in the proteolytic pathways was demonstrated. To 
further validate the correlation between the loss of disaggregation capacity with 
the autophagy and proteasome responses, and eliminate the possibility that our 
observations are due to a general chaperone effect, I analyzed both proteolytic 
pathways upon depletion of two additional chaperones. It was important to 
carefully select chaperones that do not display pleiotropic roles in cellular 
signaling pathways such as Hsp90. In addition, the selected chaperones should 
not be members of the Hsp70, Hsp110 or J-protein families. For that reason, I 
chose two small heat shock proteins, hsp-16.41 and hsp-17 that do not exhibit 
any disaggregation activity (data from Kirstein lab). 
As shown in figure 5.1, the depletion of hsp-16.41 or hsp-17 has no impact 
either on autophagy (LGG-1 and SQST-1 protein levels) or proteasome 
pathways (20S α-subunits levels and Suc-LLVY-AMC cleavage). This data 
indicates that the clearance machinery responds specifically to a loss in the 






Figure 5. 1 - Proteolytic pathways are not affected by a depletion of hsp-16.41 
and hsp-17.  
A) LGG-1, SQST-1/p62, 20S and HSP-17 protein levels of nematodes treated with the 
indicated RNAi for 4 days. B) LGG-1, SQST-1/p62, and 20S levels were normalized to 
RNAi control. The error bars represent the standard deviation from five independent 
experiments. C-D) Chymotrypsin-like proteasome activity of nematodes treated with 
the indicated RNAi for 4 days. The relative activities were calculated and normalized to 




4.5 Autophagy and proteasome response to protein misfolding  
4.5.1 Depletion of chaperones promotes cytosolic protein misfolding 
which triggers the induction of autophagy and proteasome 
impairment 
To better understand how the loss of HSP110/70/J affects the cellular folding 
capacity and the crosstalk with the proteolytic pathways, I employed a well-






































































































































































































luciferase variant, FlucDM-GFP expressed in HEK293 cells (Gupta et al. 2011, 
Park et al. 2013, Raychaudhuri et al. 2014). FlucDM contains two point 
mutations (R188Q, R261Q) that lead to rapid misfolding and aggregation in 
response to proteostasis perturbations. The enzymatic activity of luciferase can 
be assessed in the form of released light upon conversion of luciferin to 
oxyluciferin (Thorne et al. 2010).  
To monitor FlucDM-GFP misfolding and aggregation in real-time, I designed a 
live-cell imaging experiment where cells were imaged using a confocal 
microscope. As seen in figure 6.1 A, when cells were treated with MG-132, a 
strong increase of FlucDM aggregates is detectable after 6 h. The enzymatic 
activity of luciferase was monitored in parallel in the intact cells (Gupta et al. 
2011). The luciferase aggregation resulting from MG-132 treatment 
corresponded to a decrease of 45% of luciferase activity compared to control 
(Figure 6.1 B). 
 
 
Figure 6. 1 - FlucDM-GFP aggregation and activity upon proteasome inhibition. 
A) HEK293 cells expressing FlucDM-GFP were treated with 20 μM MG-132. The 
depicted images were acquired at 0 and 6 h after treatment. Scale bars: 10 μm. B) The 
FlucDM-GFP activity was measured in cells treated with 20 μM MG-132 for 6 h. The 
error bars represent the standard deviation of three independent experiments. 
 
 
Taking advantage of this reporter line, I aimed to determine the time-point by 
which luciferase starts to aggregate (and loses its activity) in response to 
chaperone depletion, and then correlate it to the induction of autophagy and 








































with siRNA against HSP110/70/J complex members and imaged for 48 h. The 
formation of the first foci representing aggregated FlucDM-GFP in response to 
chaperone depletion was detected 24 h post siRNA transfection (Figures 6.2 
A+B). At 48 h of siRNA treatment, the chaperone knockdown conditions 
displayed visible accumulation of aggregated luciferase, particularly upon 
depletion of hspa8, dnaja2, and dnajb1. In parallel, the enzymatic activity of the 
luciferase was monitored. The luciferase activity measured at different time-
points after chaperone depletion confirmed that the misfolding and subsequent 
loss of activity of luciferase occurs 24 h after siRNA transfection and at the 48 h 
time-point all chaperone siRNA conditions exhibit a prominent reduction (25-




Figure 6. 2 - FlucDM-GFP aggregation and activity upon chaperone depletion. 
A) HEK293 cells expressing FlucDM-GFP were treated with siRNA against the 
indicated genes and subjected to live-cell imaging (A). The images shown were 






























































































































































































the images acquired at 0, 8, 24 and 48 h of the live FlucDM-GFP cell imaging 
experiment (A). The green color represents no or a low number of cells with 
aggregates, whereas the red color indicates a high number of cells with aggregates. C) 
The FlucDM-GFP activity was measured 24 and 48 h after siRNA transfection. The 
luciferase activity of the chaperone knockdown conditions was normalized to the 
control siRNA luminescence of the respective time-point. The error bars represent the 
standard deviation of three independent experiments. 
 
 
This data prompted me to question if the protein clearance mechanisms were 
already affected when the cells were treated with siRNA for 24 h (previous 
experiments were performed 48 h after siRNA). Therefore, autophagy and 
proteasome pathways were additionally assessed at 24 h post siRNA treatment. 
First, the LC3-II autophagy marker was analyzed upon chaperone knockdown. 
As depicted in figure 6.3 A, LC3-II levels are slightly increased at 24 h post 
transfection but exhibit the highest level at 48 h siRNA time-point.  
Second, to assess UPS capacity, I analyzed UbG76V levels and chymotrypsin-
like proteasome activity upon siRNA treatment for 24 and 48 h. The 
accumulation of UbG76V-GFP, in particular upon hspa4 depletion, is only 
detected after 48 h of siRNA treatment (Figure 6.3 B). Despite this, a reduction 
in chymotrypsin-like proteasome activity can already be detected at the 24 h 
time-point in hspa4 and dnajb1 siRNA conditions (Figure 6.3 C). This data 
indicates that the UPS activity is already compromised 24 h post siRNA 
transfection, yet the accumulation of UPS substrates becomes prominent only 
48 h after depletion of the chaperones. 
In sum, these results suggest that depletion of chaperones leads to an 
accumulation of protein aggregates, which triggers the induction of autophagy 






Figure 6. 3 - Analysis of the autophagy and UPS capacity in HEK293 cells treated 
with HSP110/70/J siRNA for 24 and 48 h. 
A) LC3-II levels from lysates of HEK293 cells, which were transfected with the 
respective chaperone siRNA for 24 and 48 h. The LC3-II levels were normalized to α-
tubulin levels and then to siRNA control. The error bars represent the standard 
deviation of two independent experiments. B) UbG76V-GFP levels from lysates of 
HEK293 cells, which were transfected with the respective chaperone siRNA and 
UbG76V-GFP for 24 and 48 h (data shown in figure 4.5). The UbG76V-GFP levels 
were normalized to α-tubulin levels and then to siRNA control. The error bars represent 
the standard deviation of a minimum of two independent experiments. C) 
Chymotrypsin-like proteasome activity of lysates of HEK293 cells treated with the 
indicated siRNA for 24 and 48 h (data shown in figure 4.7). The relative activities were 
calculated and normalized to siRNA control. The error bars represent the standard 
deviation of a minimum of two independent experiments. 
  
 
4.6 Alzheimer and Huntington’s disease models exhibit compromised 
proteolytic pathways 
4.6.1 Aβ and PolyQ40 C. elegans models display autophagy impairment 
Aggregation and accumulation of toxic protein aggregates are a hallmark of 
neurodegenerative disorders (Ross et al. 2004). It is known that the presence of 

















































































































































































































































































2014). Yet, little is known on how these protein aggregates affect the concerted 
action of protein clearance pathways. 
To understand how autophagy pathway is affected by disease-associated 
protein aggregates, animals expressing Aβ (CL2006 [Aβ3-42]) or polyglutamine 
(AM1066 [Q40::RFP]) in the body wall muscle tissue were crossed with animals 
expressing the autophagy reporter GFP::LGG-1. As shown in figure 7.1 A, the 
expression of Aβ3-42 and Q40 led to a prominent accumulation of GFP::LGG-1 
not just in muscle tissue, but also in the head region. The levels of GFP::LGG-1 
were also determined by western blot and confirmed that Aβ3-42 (3-fold) and Q40 
(2-fold) expressing animals have elevated GFP::LGG-1 protein levels compared 




























































































































A) Fluorescent images of DA2123 (GFP::LGG-1), DA2123/CL2006 (GFP::LGG-1; 
mAβ3-42) and DA2123/AM1066 (GFP::LGG-1; mQ40::RFP) animals at day 5 of life. The 
lower panel is a magnification of the head region. Scale bars: 50 μm (upper panel) and 
5 μm (lower panel). B-C) GFP::LGG-1 levels of DA2123, DA2123/CL2006 and 
DA2123/AM1066 animals at day 5. The relative band intensities of GFP::LGG-1 were 
normalized to the α-tubulin levels and then to DA2123 (C). The error bars represent the 
standard deviation of four independent experiments. 
 
 
Neurodegenerative diseases are generally late age of onset diseases 
(Morimoto et al. 2014). Thus, I decided to investigate the autophagic flux in 
young and old Aβ3-42/Q40 animals. As depicted in figure 7.2 A, both young and 
aged Aβ3-42/Q40 expressing nematodes display increased GFP::LGG-1 
fluorescence compared to wt animals, yet day 10 Aβ3-42/Q40 animals have 
similar GFP::LGG-1 signal when compared to day 4.  Subsequently, the SQST-
1/p62 and LGG-1 protein levels were monitored in animals expressing Aβ and 
Q40 in the body-wall muscle cells (CL2006 [Aβ3-42] and AM141 [Q40::YFP]), and 
in neuronal cells (CL2355 [Aβ1-42] and AM101 [Q40::YFP]). As shown in figure 
7.2 B+C, all disease proteins led to a strong increase of LGG-1 and a slight 
increase of SQST-1/p62 in young adults, indicating that autophagy is impaired 
in those animals. As aging progresses, the impact of the disease proteins 
becomes less pronounced, and the LGG-1 and SQST-1/p62 levels are not or 
only moderately elevated in the Aβ and Q40-expressing animals compared to wt 
animals. This is supported by the fact that old animals exhibit an already 
impaired autophagic system, resulting in increased LGG-1 and SQST-1/p62 
levels (Figure 3.7). To substantiate the data set, I examined also the lysosome 
pool. Indeed, young animals expressing Aβ/Q40 either in muscle or neurons 
exhibit a prominent accumulation of the lysosome pool when compared to the 
wt (Figure 7.2 D). Taken together, this data demonstrates that autophagy is 





Figure 7. 2 - Autophagic flux analysis in neurodegenerative disease C. elegans 
models during aging. 
A) Fluorescent images of DA2123 (GFP::LGG-1), DA2123/CL2006 (GFP::LGG-1; 
mAβ3-42) and DA2123/AM1066 (GFP::LGG-1;mQ40::RFP) animals were acquired at day 
4 (left panel) and day 10 (right panel) of age. The upper, middle and lower panels show 
the whole animal, the head and a magnification of the head region, respectively. Scale 
bars: 20 μm (upper panel), 50 μm (middle panel) and 5 μm (lower panel). B-C) LGG-1 
and SQST-1/p62 levels were determined in control, CL2006 (mAβ3-42), CL2355 (nAβ1-
42), AM141 (mQ40::YFP) and AM101 (nQ40::YFP) nematodes of 4 and 10 days of age. 
The LGG-1 and SQST-1/p62 levels were normalized to α-tubulin levels and then to 
DA2123 (GFP::LGG-1) (C). The error bars represent the standard deviation of a 
minimum of three independent experiments. D) The lysosomal pool of control, CL2006 
(mAβ3-42), CL2355 (nAβ1-42), AM141 (mQ40::YFP) and AM101 (nQ40::YFP) animals at 
day 4 was stained with LysoTracker-Red and then imaged using a fluorescent 
microscope. LysoTracker-Red fluorescence was quantified and normalized to control 













































































































































































































































































4.6.2 Aβ models display proteasome impairment across tissues   
My observations that the autophagic flux is compromised in neurodegenerative 
disease models, posed the question whether the proteasome system would 
also be affected by the presence of toxic disease-associated protein aggregates.  
To address this question, the chymotrypsin-like proteasome activity (described 
in section 4.3) was monitored in animals expressing Aβ in muscle and neurons. 
As depicted in figure 7.3 A+B, nematodes expressing Aβ3-42 either in muscle 
cells or Aβ1-42 in neuronal cells exhibited reduced chymotrypsin-like proteasome 
activity (-40% and -48%, respectively). The 20S α-subunit protein levels were 
also analyzed, and a reduction of 20S α-subunits in the Aβ-expressing animals 
was detected (Figures 7.3 C+D). The reduction in the 20S α-subunits protein 






































































































































Figure 7. 3 - Ex vivo proteasome function in Aβ expressing animals. 
A-B) Chymotrypsin-like proteasome activity was measured every 5 min from lysates of 
control, CL2355 (nAβ1-42) and CL2006 (mAβ3-42) day 4 old animals. The relative 
activities were calculated and normalized to control (B). The error bars represent the 
standard deviation of three independent experiments. C-D) 20S α-subunit levels were 
determined in control, CL2355 (nAβ1-42) and CL2006 (mAβ3-42) day 4 old animals. The 
20S levels were normalized to α-tubulin levels and then to control (D). The error bars 
represent the standard deviation of three independent experiments. 
 
 
As the chymotrypsin-like proteasome activity reflects the ex vivo activity on an 
organismal level, I decided to analyze the in vivo proteasome activity in distinct 
tissues. Animals expressing Aβ were crossed with the in vivo neuronal and 
muscle proteasome-sensor UbG76V::Dendra2 (Figure 7.4 A). Both, the muscle 
and neuronal model, express Aβ without a fluorescence tag, which enables an 
accurate Dendra2 quantification. As presented in figure 7.4 B+C, animals 
expressing Aβ3-42 in the muscle tissue displayed reduced degradation rates of 
UbG76V::Dendra2 in muscle (-30%) and neurons (-45%) compared to control. 
Analogously, Aβ1-42 expressed in neurons also led to a diminished proteasome 
activity in muscle (-25%) and neuronal cells (-48%). This data shows that Aβ 
expression exerts a cross-tissue effect, which leads to defective proteasome 






Figure 7. 4 - In vivo proteasome function in Aβ expressing animals. 
A) The UbG76V::Dendra2 degradation rates were measured in YD3 
(mUbG76V::Dendra2), YD3/CL2006 (mUbG76V::Dendra2; mAβ3-42), YD3/CL2355 
(mUbG76V::Dendra2; nAβ1-42), YD12 (nUbG76V::Dendra2), YD12/CL2006 
(nUbG76V::Dendra2; mAβ3-42), YD12/CL2355 (nUbG76V::Dendra2; nAβ1-42) animals. 
B-C) UbG76V::Dendra2 protein was converted upon exposure to 405 nm, and the 
animals were imaged immediately and 3 (C) or 24 (B) hours after at 561 nm. To 
determine the degradation rates, the fluorescence (561 nm) acquired 3 or 24 h after 
the conversion was divided by the fluorescence immediately after conversion. The 
error bars represent the standard deviation of 11-15 animals. 
 
 
4.6.3 PolyQ and mHtt expression reduces proteasome capacity 
Subsequently, the proteasome function was investigated in animals expressing 
expanded polyglutamine stretches in muscle and neurons. Interestingly, 
whereas expression of Q40 in muscle tissue led to a reduction of chymotrypsin-
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like proteasome activity of 30% and analogously of the 20S α-subunit levels 
(Figures 7.5 A-D), neuronal expression of Q40 did not affect proteasomal activity 
(Figures 7.5 E). Similar results were obtained in animals expressing a longer 
polyglutamine stretch, Q67, as neither the ex vivo nor in vivo proteasome 


















































































































































































































A-B) Chymotrypsin-like proteasome activity was measured every 5 min from lysates of 
control and AM141 (mQ40::YFP) day 4 old animals. The relative activities were 
calculated and normalized to control (B). The error bars represent the standard 
deviation of three independent experiments. C-D) 20S α-subunit levels were 
determined in control and AM141 (mQ40::YFP) day 4 old animals. The 20S levels were 
normalized to α-tubulin levels and then to control (D). The error bars represent the 
standard deviation of three independent experiments. E) Chymotrypsin-like 
proteasome activity was measured every 5 min from lysates of control and AM101 
(nQ40::YFP) day 4 old animals. The relative activities were calculated and normalized to 
control. F) Chymotrypsin-like proteasome activity was measured every 5 min from 
lysates of control and AM44 (nQ67::CFP) day 4 old animals. The relative activities were 
calculated and normalized to control. The error bars represent the standard deviation 
of two independent experiments. G) The UbG76V::Dendra2 degradation rates were 
measured in YD3 (mUbG76V::Dendra2), YD3/AM44 (mUbG76V::Dendra2; nQ67::CFP) 
animals. UbG76V::Dendra2 protein was converted upon exposure to 405 nm, and the 
animals were imaged immediately and 24 h after at 561 nm. To determine the 
degradation rates, the fluorescence (561 nm) acquired 24 h after the conversion was 
divided by the fluorescence immediately after conversion. The error bars represent the 
standard deviation of 11 animals. 
 
 
To validate the data obtained in the nematode, I set out to analyze the 
proteasome function in response to mHtt aggregation in mammalian cells. As 
demonstrated in figures 7.6 A+B, HEK293 cells were transfected with GFP 


















































A-B) HEK293 cells were transfected with GFP, HttExon1Q25-GFP, and HttExon1Q97-
GFP. 24 h after transfection, cells were imaged in a fluorescent microscope (A). The 
expression of GFP, HttExon1Q25-GFP, and HttExon1Q97-GFP was also confirmed by 
western blot (B). Scale bar: 5 μm. 
 
 
The expression of the aggregation-prone HttExon1Q97-GFP led to a reduction 
of chymotrypsin-like proteasome activity by 16% compared to controls (GFP 
and HttExon1Q25-GFP) (Figures 7.7 A+B). Unlike the C. elegans data, the 
presence of amyloid-like aggregates in HEK293 cells did not affect the 20S 
levels (Figures 7.7 C+D).  
Together, these results demonstrate that Huntington’s disease models display a 
compromised proteasome function likely associated with the presence of toxic 







Figure 7. 7 - Analysis of the proteasome activity and abundance in mHtt 
expressing HEK293 cells. 
A-B) Chymotrypsin-like proteasome activity was measured every 5 min of lysates of 
HEK293 cells transfected with GFP, HttExon1Q25-GFP or HttExon1Q97-GFP. The 
relative activities were calculated and normalized to GFP (B). The error bars represent 
the standard deviation of three independent experiments. C-D) 20S α-subunit levels 
were determined in HEK293 cells transfected with GFP, HttExon1Q25-GFP or 
HttExon1Q97-GFP. The 20S levels were normalized to α-tubulin levels and then to GFP 








































































































































































































4.6.4 PolyQ40 ultrastructure by CLEM and EM 
The fact that animals expressing amyloidogenic protein aggregates exhibit an 
impairment of protein clearance pathways suggests a cellular collapse.  To gain 
insight into the structural changes of the affected cells and tissues within the 
nematode, I decided to perform a more detailed analysis of the morphology of 
the Q40 aggregates. The fluorescent features of the Q40::RFP aggregates allow 
its visualization by confocal microscopy and subsequent transmission electron 
microscopy analysis. Therefore, Correlative Light Electron Microscopy (CLEM) 
was applied to determine the ultrastructure of Q40 aggregates. Nematodes were 
embedded in HM20 resin that retained enough fluorescence enabling the 
detection of Q40::RFP, and together with nuclear DAPI staining allowed the 
alignment of confocal images with transmission electron microscopy images 
(Figure 7.8, upper panel).  The RFP signal was associated with a cytoplasmic 
part of muscle cells, and ultrastructural observation indeed revealed that the 
bright RFP foci were associated with a cytoplasmic region containing an 
electron dense fibrilar meshwork (Figure 7.8, lower panel). Similar to 
observations from transfected mouse primary cells, HeLa cells and yeast 
(Bauerlein et al. 2017, Gruber et al. 2018), the obtained Q40 aggregates in an 
animal reveal that the aggregates are devoid of ribosomes and are not 
enclosed by any membranous structure. Despite the increased GFP::LGG-1 
signal observed on the confocal level (Figure 7.1 A), autophagy-related 





Figure 7. 8 - CLEM analysis of a Q40::RFP aggregate. 
Confocal microscopy images (DAPI and RFP) were aligned with transmission electron 
images (upper and middle panel). The lower panel displays an electron microscopy 
image merged with the Q40::RFP signal. Image 1 is a magnification of the cytosol and 
image 2 depicts the Q40 aggregate. Triangles indicate the aggregate boundary. Scale 
bars: 5 μm (upper panel), 2 μm (middle panel) and 1 μm (lower panel). 
 
 
The Q40 aggregates were also analyzed in standard Epoxy embedded/osmium 
fixed nematodes to obtain a better image contrast (Figure 7.9). The Q40 
aggregate displayed an amyloid-like fibril structure, resembling in vitro 
generated HttExon1Q48 fibrils (Gao et al. 2015, Scior et al. 2018) and 
HttExon1Q97-GFP structures in transfected cells (Bauerlein et al. 2017). The 
diameter of the depicted Q40 aggregate is about 2 µm (Figure 7.9, top image; 
the dimension of the Q40 aggregate is indicated by the red triangles). Inset 1 
depicts a magnified region of a cell section outside of the polyQ aggregate that 
shows a regular distribution of ribosomes. The interface between aggregate and 
the remaining cytosol is depicted by inset 2 and demonstrates the lack of any 
membranous structure, and inset 3 depicts a magnified region within the 
aggregate that shows the amyloid fibrils and the complete lack of ribosomes.   
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Together, the CLEM and EM analysis show that the polyQ aggregates display 
an amyloid-like structure that easily can interact with cytosolic components due 




Figure 7. 9 - EM analysis of a Q40::RFP aggregate. 
In the lower panel are magnified images from the indicated regions. Image 1 is a 
magnification of the cytosol; image 2 shows the interface of the aggregate and image 3 
is a magnification of the aggregate. The arrows point out the boundaries of the 





The proteostasis network is a well-orchestrated system that tightly regulates 
protein synthesis, folding, refolding and proteolysis to maintain the function of 
the proteome and the cellular physiology (Wolff et al. 2014, Diaz-Villanueva et 
al. 2015, Sala et al. 2017). The interplay between different protein quality 
control pathways has been the focus of many studies. However, the precise 
regulation of the proteostasis machinery, especially during aging and disease, 
is still far from being completely understood (Rubinsztein et al. 2011, Kaushik et 
al. 2015).  
For this reason, I decided to investigate the crosstalk between the disaggregase 
constituting chaperones and the two major proteolytic pathways, the UPS and 
autophagy (Figure 8.1 A). A response of autophagy and UPS was observed 
when proteins of the HSP110/70/J disaggregation complex were depleted in C. 
elegans and HEK293 cells. Notably, the depletion of chaperones that are not 
involved in protein disaggregation did not affect autophagy and proteasome 
pathways.  
Moreover, the UPS and autophagy pathways were assessed with the 
progression of aging and in neurodegenerative disease models (Figure 8.1 B). I 
found that the protein clearance pathways are altered in old animals, and 






Figure 8. 1 - Summary scheme. 
A-B) Depletion of HSP110/70/J disaggregation complex members leads to an increase 
of misfolded proteins, which induces autophagy and impairs proteasome function in 
young animals and HEK293 cells (A). With the progression of aging in C. elegans, 
autophagy is not activated, and proteasome activity is no longer reduced in response 
to chaperone loss. Autophagy and proteasome pathways are perturbed in the 




5.1 Autophagy is induced upon loss of disaggregation capacity  
The recently described HSP110/70/J disaggregation complex can prevent and 
reverse the aggregation of multiple substrates, thus providing the cell with an 
alternative protein aggregate clearance pathway (Rampelt et al. 2012, Nillegoda 
et al. 2015, Kirstein et al. 2017, Scior et al. 2018). In this study, I demonstrated 
that the depletion of chaperones that form the disaggregation complex leads to 
an activation of autophagy in C. elegans and HEK293 cells (section 4.2). The 
activation of autophagy was detected in young animals, which displayed 
elevated LGG-1 and reduced SQST-1/p62 protein levels, in response to 
chaperone depletion. Also, chaperone knockdown led to a decrease of the 
lysosome pool in C. elegans confirming the activation of autophagic flux. I was 
also able to show that chaperone siRNA induced autophagy in HEK293 cells.  
Moreover, I could demonstrate that the activation of autophagy is regulated at 
the transcriptional level as hsp-1 and hsp-110 depletion leads to a nuclear 
translocation of the transcription factor HLH-30 that initiates the gene 
expression program to activate autophagy.  
 
Aging is marked by an accumulation of misfolded proteins due to the collapse of 
protein quality control mechanisms (Ben-Zvi et al. 2009, David et al. 2010, 
Kirstein-Miles et al. 2013). However, the regulation of autophagy during aging is 
far from consensual. An impairment (Chang et al. 2017) as well as activation of 
autophagy (Chapin et al. 2015) during aging have been reported for C. elegans, 
which emphasizes the need to further investigate the autophagic flux in aged 
animal models. Here, I monitored the LGG-1 and SQST-1/p62 protein levels of 
both young and old animals and detected an increase in the levels of both 
proteins in aged animals. Thus, it can be concluded that the autophagic flux is 
less active with the progression of aging, supporting a previous study (Chang et 
al. 2017). Additionally, I found that the induction of autophagy in response to 
chaperone depletion is diminished in old animals, implying that the 
compensatory effect of autophagy to maintain proteostasis is limited to the 
reproductive phase of animals. This observation is supported by previous work 
from Ben-Zvi and colleagues, which demonstrated that the maintenance of 
proteostasis occurs only until the reproductive phase (progeny production) and 
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then collapses in the adulthood phase (Ben-Zvi et al. 2009, Shemesh et al. 
2013). Particularly, after the reproductive stage, there is a sharp decline in the 
capability to activate proteostasis mechanisms like the heat-shock response 
(Ben-Zvi et al. 2009). So, it is possible that autophagy is regulated analogously, 
restricting an activation of the autophagic flux in response to stress to a narrow 
window until adulthood is reached. 
 
In summary, I was able to show that autophagy is activated in response to the 
loss of chaperone-mediated disaggregation in HEK293 cells and C. elegans. 
Yet, as aging progresses, the autophagic flux is diminished, and old animals 




5.2 Proteasome capacity is diminished when HSP110/70/J machinery is 
compromised  
The capacity of the proteasome system was also studied in response to the loss 
of disaggregation activity. Both ex and in vivo analysis of proteasome function 
revealed that depletion of some chaperones constituting the disaggregation 
complex leads to a decreased proteasome activity, and accumulation of 
proteasomal substrates in C. elegans and HEK293 cells (section 4.3). 
Interestingly, the depletion of hsp-110/hspa4 showed the most robust 
phenotype. The knockdown of hsp-110 led to a prominent reduction of 
chymotrypsin-like proteasome activity and a notable accumulation of UbG76V in 
the muscle and neurons of C. elegans. Similar results were obtained in HEK293 
cells when hspa4 was depleted. The distinct biological function of HSP-110 
described so far may explain these results. HSP-110 is essential for protein 
disaggregation, due to its nucleotide exchange factor activity as part of the 
disaggregation complex (Rampelt et al. 2012). No other function has been 
described so far yet for HSP-110. Moreover, the C. elegans genome encodes 
for only one hsp-110 gene, which implies that the knockdown of hsp-110 
completely abrogates the disaggregation activity.  
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A reduction of proteasome capacity can be attributed to a failure in substrate 
recognition, enzymatic activity deficiencies or reduced proteasome proteins. 
The latter is likely to be the case, as the levels of the 20S α-subunit proteins are 
decreased when hsp-110 and dnj-12 are depleted in C. elegans, and upon 
knockdown of hspa8, dnaja2 and dnajb1 in HEK293 cells.  
Intriguingly, the depletion of chaperones from the J-protein family led to the 
highest discrepancies in the phenotypes detected between C. elegans and 
HEK293 cells. These observations may be related to the huge diversity of J-
proteins. The J-protein family is comprised of 32 and 49 members in C. elegans 
and humans, respectively (Hageman et al. 2009, Craig et al. 2017). The precise 
biological role for every J-protein family member is still unknown and the 
orthologous proteins between species may exhibit different functions. In 
addition, compensatory effects have been observed between distinct J-protein 
members, where a depletion of a specific J-protein led to an upregulation of 
another (unpublished data, Kirstein laboratory).  
Furthermore, the diversity of the Hsp70 protein family could also explain the 
variation of the phenotypes observed upon hsp-1 depletion. The complete 
disaggregation of amorphous and amyloid aggregates (e.g. luciferase and 
mHtt) is only possible when HSP-1 acts together with HSP-110 and a J-protein 
(Rampelt et al. 2012, Nillegoda et al. 2015, Kirstein et al. 2017, Scior et al. 
2018). However, other Hsp70s (C12C8.1, F11F1.1 an F44E5.4) also possess a 
residual disaggregation activity. It was shown that C12C8.1 is able to solubilize 
in part aggregated luciferase, and that an excessive amount of C12C8.1, 
F11F1.1 or F44E5.4 can prevent mHtt aggregation (Kirstein et al. 2017, Scior et 
al. 2018). Interestingly, the depletion of hsp-1 leads to an upregulation of more 
than six-fold of C12C8.1 (Guisbert et al. 2013). Yet, the increasing levels of 
C12C8.1 do not compensate for the loss of the disaggregation activity of HSP-1 
(Kirstein et al. 2017). 
The high complexity of the Hsp70 and J-protein family, needs to be taken into 
account when analyzing the severity of the observed phenotypes in the 
knockdown conditions, as they could be underestimated and masked by 
compensatory effects.  
Analogous to autophagy, the proteolytic capacity of the UPS is a vital node of 
the proteostasis network and plays an important role during aging. Yet, the 
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regulation of proteasome function with the progression of aging requires 
additional studies, as opposing data have been published. While it has been 
reported that the lung, liver, heart and spinal cord of aged rat exhibit a 
decreased proteasome activity (Keller et al. 2000, Bulteau et al. 2002, Breusing 
et al. 2009), others have reported that muscle, liver, and spleen display an 
increased proteasome function (Shibatani et al. 1996, Zhang et al. 2007, Altun 
et al. 2010). Moreover, impaired proteasome function or even no change was 
detected in aged Drosophila and mice, respectively (Vernace et al. 2007, Cook 
et al. 2009, Tonoki et al. 2009, Caniard et al. 2015). In C. elegans, the 
chymotrypsin-like proteasome activity was reported to be increased on day 10 
when compared to day 3 animals (Raynes et al. 2017). Also, the degradation of 
UbG76V::GFP in the epithelial cells of C. elegans revealed an increased 
proteasome activity during aging (detected 48 h after L4 stage) (Liu et al. 2011). 
 
In this thesis, I further analyzed the proteasome function during aging in C. 
elegans, and found that the 20S α-subunit protein levels increase as the 
nematodes age, but the overall chymotrypsin-like activity remained unchanged. 
These results prompted me to analyze the in vivo proteasome activity in 
different cellular compartments. I observed that while old animals display an 
increased proteasome activity in muscle cells, the UPS activity declines in 
neurons (Hamer et al. 2010), revealing a coordinated tissue-specific regulation 
of the proteasomal activity with aging. Notably, the reduced proteasome 
capacity in response to the depletion of some disaggregating members (hsp-
110, dnj-12 and dnj-13) is no longer observed in old animals, likely due to an 
increase of the 20S α-subunit levels when hsp-110, dnj-12, dnj-13, and dnj-19 
are depleted.  
 
This data demonstrates that proteasome function is decreased in young 
nematodes and HEK293 cells when specific chaperones from the 
disaggregation complex are depleted. With the progression of aging, the 
proteasome capacity is altered in C. elegans, and it exhibits a tissue-specific 
proteasome regulation.  
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5.2.1 The decline of the proteolytic pathways during aging 
Proper regulation of the proteolytic pathways is vital for healthy aging, as a 
decline in degradative pathways leads to the accumulation of damaged 
proteins, organelles, and reduced ability to adapt and respond to stress 
conditions such as bacterial infection (Shintani et al. 2004, Vilchez et al. 2014). 
Besides, the activity of the protein degradation pathways is crucial for the 
immune system and protein synthesis, as its proteolytic activity generates 
antigenic peptides that will be presented to the immune system and free amino 
acids that will be transformed to obtain energy or recycled to synthesize new 
proteins (Gaczynska et al. 1993, Mizushima et al. 2011). The latter is of high 
relevance due to the observed decrease in protein synthesis during aging 
(Kirstein-Miles et al. 2013, Walther et al. 2015). Therefore, the reduced activity 
of the UPS and autophagy during aging, not only leads to the accumulation of 
damaged organelles, increase in the half-life and stability of proteins, but also 
may contribute to the reduction of protein synthesis. 
Supporting the importance of proteasome and autophagy pathways during 
aging is the fact that their activities are increased and contribute to the lifespan 
extension observed in the daf-2 mutants (Melendez et al. 2003, Ghazi et al. 
2007, Hansen et al. 2008, Matilainen et al. 2013). Indeed, the extension of 
lifespan can be achieved by the activation of the proteolytic pathways, as this 
was reported when autophagy was activated in C. elegans (Kenyon 2010), 
Drosophila (Bjedov et al. 2010) or mice (Harrison et al. 2009), or when 
proteasome activity was increased in C. elegans (Chondrogianni et al. 2015), 
Drosophila (Tonoki et al. 2009) or yeast (Kruegel et al. 2011). 
 
Although my data helped to get more insight into the role of the diverse 
proteostasis pathways during aging, many open questions remain regarding the 
mechanism of how the activity of the proteolytic pathways are adjusted with 
aging. Further analysis should ideally be carried out in different model 





5.2.2 Are the proteolytic pathways reacting to the loss of disaggregation 
capacity due to an increase in protein misfolding? 
It is challenging to untangle the crosstalk between the disaggregating 
chaperones and the proteolytic pathways. Is there a strict sequence of events 
upon loss of cellular disaggregation capacity that leads to a subsequent 
regulation of autophagy and proteasome? I aimed to address this question and 
found that HSP110/70/J complex member depletion leads to a prominent 
increase of amorphous aggregates and loss of protein function, followed by the 
activation of autophagy and reduction of proteasome function (section 4.5). The 
expected accumulation in cytosolic protein misfolding in consequence of 
chaperone depletion, likely triggers the induction of autophagy as a 
compensatory mechanism to rebalance protein homeostasis. However, a clear 
separation of the functional role of chaperones as constituents of a 
disaggregase complex and the two proteolytic pathways is difficult.  
This aspect is of particular relevance for Hsp70 family members that fulfill 
pleiotropic functions and are not only active in a trimeric disaggregase complex. 
Hsp70 is known to participate in the autophagy process, particularly its role in 
chaperone-mediated autophagy (CMA) is well established (Cuervo et al. 2014). 
Therefore, the involvement of other chaperones from the disaggregase complex 
in targeting substrates for degradation cannot be excluded. Indeed, a possible 
involvement of DNAJB1 in the autophagy pathway was proposed due to its 
interaction with WIPI2, an autophagy-related protein (Behrends et al. 2010).  
In addition, it has been shown that heat-shock can promote the induction of 
autophagy via HSF-1 in C. elegans (Kumsta et al. 2017). Moreover, the 
depletion of specific chaperones (hsp-1/Hsp70, daf-21/Hsp90) induces a robust 
heat-shock response in C. elegans, thus interfering with the autophagy-
signaling pathway (Guisbert et al. 2013, Haslbeck et al. 2013).  
 
The interplay between the UPS and chaperones has been investigated as well, 
and for instance, Hsp70 was shown to be involved in the targeting of misfolded 
poly-ubiquitinated proteins to the proteasome (Esser et al. 2004, Kriegenburg et 
al. 2012). The targeting of misfolding proteins to the proteasome by other 
disaggregation chaperones like the HSP-110 has not yet been proposed. 
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However, it cannot be excluded that additional chaperones that participate in 
disaggregation events also play a role in the proteasomal degradation of 
specific substrates.  
Furthermore, the proteasome complex assembly is assisted by five chaperones, 
the proteasome assembly chaperones, PAC1-4 (Rousseau et al. 2018). A 
recent study showed that yeast proteins from the Hsp70 family are required in 
the proteasome assembly cascade, and thus achieving a functional proteasome 
structure (Hammack et al. 2017). As discussed above, the depletion of some 
disaggregating chaperones leads to a reduction of essential proteasome 
complex subunits. A plausible explanation would be the involvement of these 
chaperones either in the folding of proteasome-related proteins, or even in 
proteasome assembly. Another scenario would be linked to a reduction in the 
stability of the proteasome subunits upon chaperone down-regulation and may 
affect its stability in the cell. As the depletion of chaperones activates 
autophagy, one might also speculate that the reduction of proteasome levels 
can be linked to increased degradation. In the last years the degradation of 
proteasomes by autophagy (proteophagy) has been described (Marshall et al. 
2015, Cohen-Kaplan et al. 2016, Marshall et al. 2016, Waite et al. 2016). Yet, 
this mechanism has not been demonstrated in C. elegans, and therefore further 
studies are required to reveal if the nematodes exhibit the ability to degrade 
proteasome via autophagy. 
 
These results demonstrate that the depletion of chaperones diminish the 
cellular folding capacity, leading to the accumulation of misfolded proteins, 




5.3 Alzheimer and Huntington’s disease models exhibit an impaired 
autophagy 
The formation and accumulation of amyloid-like aggregates is a shared 
characteristic of multiple neurodegenerative diseases such as Alzheimer’s or 
Huntington’s disease (Ross et al. 2004, Park et al. 2013). The aggregation of 
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disease-related proteins is associated with a collapse of protein quality 
mechanisms that fail to maintain the solubility of these aggregation-prone 
proteins or to eliminate them by disaggregation or proteolysis.  
A failure in the autophagy pathway has been linked to neurodegeneration 
(Wong et al. 2010, Zheng et al. 2016). In this study, I investigated the 
autophagic flux in Alzheimer and Huntington’s disease models. The analysis of 
animals expressing disease-associated amyloid proteins revealed that 
autophagy is impaired irrespective of the type of amyloid (Aβ and Q40) and 
expression pattern (neuronal and muscle tissue). An accumulation of LGG-1, 
SQST-1/p62, and an increase in the lysosome pool indicates that the amyloid-
like proteins block the autophagy pathway (section 4.6.1). These toxic proteins 
are targeted to autophagy, thus the degradation attempt may lead to an 
overload of autophagosomes and subsequently lysosomes. Similar 
observations were reported in other disease models, suggesting a more general 
inhibitory effect on autophagy by amyloid-like proteins (Li et al. 2008, Winslow 
et al. 2010, Nixon 2013, Menzies et al. 2015). Moreover, a direct interaction of 
the amyloid protein either in its soluble, oligomeric or aggregated state with 
autophagic components is likely to occur, as demonstrated for mHtt which can 
interact with bec-1 resulting in autophagy impairment (Ashkenazi et al. 2017). 
 
In sum, the expression of both Aβ and Q40 in the muscle or neurons of C. 
elegans leads to the impairment of autophagy, supported by the accumulation 
of the LGG-1 and SQST-1/p62 proteins, and lysosomes. 
 
 
5.4 Proteasome function is diminished in Alzheimer and Huntington’s 
disease models 
Proteasome dysfunction has been linked to many neurodegenerative diseases. 
Despite the ability of proteasomes to degrade aggregation-prone proteins, 
various studies show that amyloid proteins can lead to an impairment of 
proteasome function (Bence et al. 2001, Lopez Salon et al. 2003, Bennett et al. 
2005, Juenemann et al. 2013) 
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Indeed, the presence of Aβ and Q40 diminishes the proteasome capacity in C. 
elegans (sections 4.6.2 and 4.6.3). I was able to demonstrate that the reduction 
in chymotrypsin-like proteasome activity correlates with a substantial reduction 
in the 20S α-subunit protein levels in C. elegans, particularly in animals 
expressing Aβ in the muscle cells. In addition, I detected that the expression of 
the aggregation-prone HttExon1Q97-GFP in HEK293 cells also leads to a 
reduction of the chymotrypsin-like proteasome activity, confirming previous data 
involving similar mHtt aggregation-prone constructs (Bence et al. 2001, Bennett 
et al. 2005, Hipp et al. 2012). 
Furthermore, I found that the presence of Aβ in the muscle cells led to a 
diminished proteasome capacity within the muscle cells, but notably also in the 
neurons. A similar phenomenon was also observed when Aβ was expressed in 
the neurons. A suppression of UPS activity in a distal tissue by the expression 
of Aβ has not yet been reported.  
What could be a potential mechanism by which Aβ expression leads to UPS 
dysfunction across tissues? The presence of Aβ exerts a severe organismal 
proteotoxic stress, which likely explains the failure of protein quality control 
mechanisms in diverse tissues. A possible explanation for this effect could be a 
transmission of Aβ peptides, oligomers or aggregates between different cell 
types. Spreading of toxic proteins plays a critical role in the manifestation of 
neurodegenerative diseases (Guo et al. 2014). Interestingly, the transmission of 
toxic proteins between tissues has been observed in C. elegans for the NM 
region of the prion Sup35 (Nussbaum-Krammer et al. 2013). In a recent study, 
the release of Q128 and Aβ1-42 was observed from neurons of C. elegans 
(Melentijevic et al. 2017). The neurotoxicity caused by expression of the 
amyloid-like proteins, led to the excretion of vesicles (named exophers) 
containg organelles, Q128, and Aβ1-42, which likely disturb the neighboring 
tissues. 
Also, the signaling communication between different cell types must be 
considered. Notably, a trans-tissue chaperone signaling mechanism has been 
demonstrated in C. elegans (van Oosten-Hawle et al. 2014). It was shown that 
Hsp90 overexpression in muscle cells leads to the upregulation of Hsp90 in the 
neuronal and intestinal cells (van Oosten-Hawle et al. 2013). Moreover, the 
toxicity observed in animals expressing Aβ in muscle cells was dramatically 
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reduced after overexpression of Hsp90 in the neurons, demonstrating the 
impact of transcriptional regulation in a trans-tissue manner (O'Brien et al. 
2018). So, it is possible that chaperones involved in disaggregation events 
share a similar trans-tissue signaling regulation.   
 
How do amyloid-like proteins affect UPS function? 
Many studies have shown that protein aggregates of disease-related proteins 
sequester numerous endogenous proteins, and amongst those components of 
the clearance pathways (e.g. proteasome proteins) and chaperones (Bence et 
al. 2001, Park et al. 2013, Walther et al. 2015, Yang et al. 2016, Thibaudeau et 
al. 2018). The mechanisms by which the amyloid-like proteins associate and 
impair the proteasome have been studied (Bence et al. 2001, Yang et al. 2016, 
Thibaudeau et al. 2018). A recent in vitro analysis revealed that Aβ, mHtt and α-
syn oligomers directly bind to the proteasome preventing the opening of the 
19/20S subunits, and consequently leading to proteasome dysfunction 
(Thibaudeau et al. 2018). 
The sequestration of proteasomes by amyloid-like protein aggregates has also 
been demonstrated and is of particular interest because it was shown that 
active proteasomes co-localize with mHtt aggregates (Schipper-Krom et al. 
2014). Also, a recent study, demonstrated that proteasomes strongly 
accumulate and are trapped within a poly-Gly-Ala aggregate, an amyloid 
aggregate associated with ALS (Guo et al. 2018). Together, the binding of 
amyloid aggregates to proteasomes and subsequent sequestration may lead to 
the reduction of the available proteasomal pool and likely explains the 
diminished proteasome function.     
 
This data shows the challenge that the proteostasis network faces in the 
presence of amyloid-like proteins. The proteasome capacity is diminished in 
Q40, but especially in Aβ-expressing animals, which display proteasome loss of 





5.5 Q40 aggregates exhibit an amyloid fibril structure without a 
surrounding membrane  
Amyloid-like aggregates are found in most neurodegenerative diseases (Chiti et 
al. 2006). However, it remains unclear how these aggregates structurally affect 
diverse cellular components. In this study, I aimed to address this question and 
analyzed the Q40 aggregate ultrastructure by CLEM and EM (section 4.6.4). I 
found that Q40 aggregates are a rounded amyloid fibril structure with a diameter 
of about 2 µm that is not enclosed by a membrane. The lack of a surrounding 
membrane exposes the amyloid fibrils directly to all cytosolic components. 
Thus, the aggregate can easily interfere with cellular functions by sequestration 
of for instance, chaperones and components of the clearance pathways 
(Holmberg et al. 2004).  
This amyloid-like aggregate ultrastructure obtained from C. elegans is similar to 
a recent cryo-electron tomographic analysis of mouse primary and HeLa cells 
transfected with HttExon1Q97-GFP (Bauerlein et al. 2017). Interestingly, 
Bauerlein and colleagues found that polyQ aggregates are also not membrane-
enclosed and that the fibrilar structures protrude the endoplasmic reticulum 
(ER) membranes, altering its dynamics. Another recent work (discussed above) 
showed that the poly-Gly-Ala aggregate sequesters proteasomes instead of 
interacting with ER membranes (Guo et al. 2018).  
 
The recent ultrastructure analysis of disease-associated protein aggregates 
demonstrates the need to comprehend the exact content composition of the 
toxic aggregates further and elucidate how the sequestration of cellular 
components affects global cellular physiology. The sequestration of cellular 
components by the aggregates is likely to perturb numerous cellular functions, 
which consequently causes the collapse of proteostasis.  
 
5.6 Conclusion and future perspectives 
The interplay between different proteostasis mechanisms is vital to preserve a 
cellular physiology and prevent the development of numerous diseases.  
In this thesis, I investigated the crosstalk between the chaperone-mediated 
disaggregation and degradation pathways, which comprise the proteostasis 
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network. I was able to show that in C. elegans and HEK293 cells, the proteolytic 
pathways (autophagy and UPS) respond distinctly to a loss of chaperone 
disaggregation capacity (HSP110/70/J). While autophagy is activated to 
compensate for the increase of protein misfolding generated by the depletion of 
HSP110/70/J complex members, the proteasome function is diminished in 
particular upon knockdown of hsp-110/hspa4.   
Interestingly, the activation of autophagy is restricted to the reproductive phase 
of C. elegans, which supports a collapse of proteostasis mechanisms with the 
progression of aging. Indeed, I found that the autophagic flux is reduced in old 
animals, and the UPS function is diminished in the neurons of C. elegans. 
However, the muscle cells exhibit increased proteasomal degradation, 
indicating that UPS function is regulated in a tissue-specific manner. 
Moreover, I demonstrated that both proteolytic pathways (autophagy and UPS) 
are impaired in Alzheimer and Huntington’s disease models. Notably, animals 
expressing Aβ revealed a reduction in proteasome activity in a distal tissue-
manner. These results show that Aβ toxicity is not limited to the cells where it is 
expressed, suggesting a complex cross-tissue communication in C. elegans. 
Finally, the analysis of the ultrastructure of Q40 aggregates revealed a non-
membrane enclosed amyloid structure. The lack of a surrounding membrane 
may explain the interaction and sequestration of critical cellular components by 
amyloid aggregates. 
 
The work presented in this thesis advances the understating of the role of 
distinct proteostasis pathways during aging and disease. It also opens new 
avenues for further studies, as it will be of high relevance to deeply understand 
how autophagy and UPS sense the loss of disaggregation capacity. Which 
protein(s) detects the increase of protein misfolding? Do disaggregating 
chaperones apart from HSP-70 participate in proteolytic events by targeting 
proteins to degradation? Moreover, the regulation of the proteolytic pathways 
during aging should be further explored in additional organismal models by 
taking advantage of in vivo tools. Lastly, there is a need to understand in deep 
detail how amyloid proteins affect proteostasis and how the sequestration of 
cellular components by amyloid aggregates perturbs the cellular and organismal 
physiology. 
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Standard chemicals were purchased from Sigma Aldrich (St. Louis, USA), Carl Roth (Karlsruhe, 
Germany) and Merck (Darmstadt, Germany).  
 
Chemical Company 
Acetone Sigma Aldrich, St. Louis, USA 
Acetonitrile (ACN) Carl Roth, Karlsruhe, Germany 
Agar-Agar Kobe 1 Carl Roth, Karlsruhe, Germany 
Agarose Bio+Sell, Nürnberg, Germany 
AmbionTM TRIzolTM reagent Thermo Fisher Scientific, Waltham, USA 
Ampicillin Carl Roth, Karlsruhe, Germany 
APS Carl Roth, Karlsruhe, Germany 
Beta-mercaptoethanol Carl Roth, Karlsruhe, Germany 
Bromphenol blue Carl Roth, Karlsruhe, Germany 
BSA Carl Roth, Karlsruhe, Germany 
Chloroform Fisher Scientific, Schwerte Germany 
Chloroquine Cell signaling, Massachusetts, United States 
Cholesterol Sigma Aldrich, St. Louis, USA 
cOmpleteTM Protease inhibitor cocktail Roche Diagnostics, Mannheim, Germany 
Coomassie Brillant Blue R-250 Carl Roth, Karlsruhe, Germany 
DAPI Carl Roth, Karlsruhe, Germany 
Digitonin Sigma Aldrich, St. Louis, USA 
DMEM (Fluorobite) Thermo Fisher Scientific, Waltham, USA 
DMEM (Gibco) Thermo Fisher Scientific, Waltham, USA 
DMSO Carl Roth, Karlsruhe, Germany 
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dNTP Mix 10 mM Thermo Fisher Scientific, Waltham, USA 
DTT Carl Roth, Karlsruhe, Germany 
Epoxy Sigma Aldrich, St. Louis, USA 
Fetal calf serum Sigma Aldrich, St. Louis, USA 
Formaldehyde (37%) Carl Roth, Karlsruhe, Germany 
Glycerol Sigma Aldrich, St. Louis, USA 
Glutamine (Gibco) Thermo Fisher Scientific, Waltham, USA 
Glutaraldheyde Sigma Aldrich, St. Louis, USA 
Gold powder 0,3-3 micron/99,9 % Chempur, Karlsruhe, Germany 
HEPES Carl Roth, Karlsruhe, Germany 
HM20 Polysciences, Eppelheim, Germany 
IPTG Thermo Fisher Scientific, Waltham, USA 
LB agar Serva, Heidelberg, Germany 
LB medium Carl Roth, Karlsruhe, Germany 
Lead citrate Sigma Aldrich, St. Louis, USA 
Levamisole AppliChem GmbH, Darmstadt, Germany 
L-lysine Sigma Aldrich, St. Louis, USA 
Lysotracker-Red DND-99 Thermo Fisher Scientific, Waltham, USA 
Magnesium acetate Carl Roth, Karlsruhe, Germany 
Methanol Fisher Scientific, Schwerte Germany 
3-methyladenine Sigma Aldrich, St. Louis, USA 
MG132 Sigma Aldrich, St. Louis, USA 
Milk powder Carl Roth, Karlsruhe, Germany 
NP-40 Surfactant Amps® Thermo Fisher Scientific, Waltham, USA 
Nuclease free water Carl Roth, Karlsruhe, Germany 
Osmium Sigma Aldrich, St. Louis, USA 
Penicillin (Gibco) Thermo Fisher Scientific, Waltham, USA 
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PMSF Sigma Aldrich, St. Louis, USA 
Potassium acetate Carl Roth, Karlsruhe, Germany 
Rapamycin Sigma Aldrich, St. Louis, USA 
RNAse away Carl Roth, Karlsruhe, Germany 
Rotiphorese® Gel 30 (37.5:1) Carl Roth, Karlsruhe, Germany 
Roti-Quant Carl Roth, Karlsruhe, Germany 
SDS Carl Roth, Karlsruhe, Germany 
Sodium azide Carl Roth, Karlsruhe, Germany 
Sodium hypochloride solution Fisher Scientific, Schwerte Germany 
Streptomycin (Gibco) Thermo Fisher Scientific, Waltham, USA 
Suc-LLVY-AMC Enzo, New York, United States 
Tannic acid Sigma Aldrich, St. Louis, USA 
TEMED Carl Roth, Karlsruhe, Germany 
Triton X-100 Carl Roth, Karlsruhe, Germany 
Trypsin-EDTA 10x (Gibco) Sigma Aldrich, St. Louis, USA 
Tween 20 Carl Roth, Karlsruhe, Germany 
Uranyl acetate Sigma Aldrich, St. Louis, USA 
 
6.1.2 Markers and loading dyes 
Product Company 
DNA loading dye (6x) Thermo Fisher Scientific, Waltham, USA 
GeneRuler (1kb, 50 bp) Thermo Fisher Scientific, Waltham, USA 




Antibody Source Dilution Source/ Company 
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Anti-LGG-1 Rabbit 1:1000 Kirstein lab/ Pineda 
Antikörper-Service, 
Berlin, Germany 
Anti-SQST-1/p62 Rabbit 1:1000 Kirstein lab/ Pineda 
Antikörper-Service, 
Berlin, Germany 




















Anti-HSP-17 Rabbit 1:4000 Kirstein lab/ Pineda 
Antikörper-Service 
Anti-LC3 Rabbit 1:1000 Abcam, Cambridge, 
UK 
Anti-DNAJB1 Rabbit 1:1000 Proteintech, 
Manchester, UK 
Anti-20S α-subunits Mouse 1:1000 Enzo New York, 
United States 
Anti-α-tubulin Mouse 1:2500 Sigma Aldrich, St. 






Antibody Source Dilution Company 
Goat-Anti-Mouse IR 
680  
Goat 1:10 000 LI-COR, Lincoln, USA 
Pierce®-Goat-Anti-
Mouse IgG + IgM 
(H+L) Peroxidase 
Conjugated 




Rabbit IgG (H+L) 
Peroxidase 
Conjugated 




6.1.4 Buffer, solutions and plates 
Buffer  Composition 
LB agar-amp plates (sterile) 35 g/l LB Agar 
1 mM Ampicillin 
 
LB-amp medium (sterile) 25 g/l LB 
1 mM Ampicillin 
 
Liquid culture solution (sterile) 1x S-Basal  
1 mM MgSO4 
1 mM CaCl2 
5 µg/ml Cholesterol 
 
Lysis buffer (C. elegans) 20 mM HEPES 
110 mM KAc 
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2 mM MgAc2  
100 µM Digitionin 
 
Lysis buffer (HEK293 cells) 50 mM Tris/HCl pH 7.4 
150 mM NaCl 
1 mM EDTA 
1 % Triton-X100 
 
2x complete protease inhibitor  
M9 solution (sterile) 58 g/l Na2HPO4 
30 g/l KH2PO4 
5 g/l NaCl 
10 g/l NH4Cl2 
 
NGM agar (sterile) 51.33 mM NaCl 
2.5 g/l BactoTM Peptone 
17 g/l Agar-Agar Kobe 1 
5 µg/ml cholesterol 
1 mM CaCl2 
1 mM MgSO4 
25 mM KH2PO4 pH 6.0 
 
PBS (10x) 1.37 M NaCl 
27 mM KCl 
100 mM Na2HPO4 
18 mM KH2PO4 
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PBST (1x) 1x PBS 
0.05% Tween 20 
 
RNAi NGM agar (sterile) NGM agar 
1 mM IPTG 
1 mM Ampicillin 
 
Sample loading buffer (C. elegans, 2x) 50 mM Tris-HCl pH 6.8 
2 % SDS 
15 % glycerol 
0.1 % bromphenol-blue 
100 mM DTT 
 






SDS PAGE distaining solution 40% methanol 
10% acetic acid 
 
SDS PAGE staining solution 2.5 g/l Coomassie brilliant blue 
40% methanol 
10 % acidic acid 
 
SDS-PAGE running buffer (10x) 1% (w/v) SDS 
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250 mM Tris  
1.92 M Glycin 
 
Separation gel buffer 1.5 M Tris-HCl pH 8.8 
0.4 % SDS 
 
Stacking gel buffer 0.5 M Tris-HCl pH 6.8 
0.4% SDS 
 
TAE buffer (50x) 242 g/l Tris, 
57.1 ml/l Glacial Acidic Acid 
100 ml/l 0.5 M EDTA pH 8.0 
 
TBS (10x) 200 mM Tris 
1.5 M NaCl 
 
TBST (10x) 200 mM Tris 
1.5 M NaCl 
1% Tween 20 
 
WB transfer  Bio-Rad Trans-blot Buffer 
 
6.1.5 Kits 
Product Name Company 
cDNA synthesis Maxima First Strand cDNA Synthesis Kit 
for RT-qPCR 
Thermo Fisher Scientific, 
Waltham, USA 
ECL Detection kit Pierce ECL Western Blot Substrate Thermo Fisher Scientific, 
Waltham, USA 
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Luciferase activity Steady-Glo Luciferase mix Promega, Wisconsin, United 
States 
qRT-PCR Luminaris Color HiGreen qPCR Mast 
Mix, high ROX 
Thermo Fisher Scientific, 
Waltham, USA 








Primer for qRT-PCR 
Primer Sequence Concentration 
(µM) 
cdc-42_F AAACTTGTCTCCTGATCAGCT 0.3 
cdc-42_R TACTGTGACGGCGTAATTGT 0.3 
lgg-1_F GTCCAGAAGATGCTCTGTTCT 0.3 
lgg-1_R GGAACAAGTCTTCCTCGTGA 0.3 
 
6.1.7 Equipment 
Device Name Company 
Agarose gel electrophoresis 
system 
 
Carl Roth, Karlsruhe, Germany 
Balances 440-49N and PCB Kern, Balingen, Germany 
Cell culture flow hood BDK® Weiss Technik, Lindenstruth, Germany 
Centrifuge  Heraeus Fresco 17 Thermo Fisher Scientific, Waltham, 
USA 
Centrifuge (15 ml/50 ml tubes) 3K12 SIGMA, Osterode am Harz, Germany 
Centrifuge (4x 8-PCR tubes) Ministar VWR, Radnor, USA 
Centrifuge (6x 1.5ml) 
 
Carl Roth, Karlsruhe, Germany 
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Centrifuge (6x 1l) Sorvall LYNX 6000 
Rotor: F9-6x1000 LEX 
Thermo Fisher Scientific, Waltham, 
USA 
Centrifuge (Rotor F45-30-11 
05844) 
5417C Eppendorf, Hamburg, Germany 
Centrifuge 4°C (Rotor F45-30-
11 01599) 
5417C Eppendorf, Hamburg, Germany 
Electron Microscope Zeiss 900 Zeiss, Oberkochen, Germany 
Fluorescence microscope EPI-TIRF Nikon, Tokio, Japan 
Fluorescence microscope M165FC Leica, Wetzlar, Germany 
Freeze substitution processor 
with UV light (EM) 
AFS Leica, Wetzlar, Germany 
Freezer (-80) KM-DU73Y1E Panasonic, Kadoma, Japan 
Gamma irradiator OB29 STS, Braunschweig, Germany 
Gel documentation (agarose 
gel) 
G:Box Syngene, Cambridge, UK 
Grids (EM)  Sigma Aldrich, St. Louis, USA 
Heating block incubator HLC  Ditabis, Pforzheim, Germany 
High pressure freezer HPM100 Leica, Wetzlar, Germany 
Homogenizer  Precellys®24 Bertin instruments, Montigny-le-
Bretonneux, France 
Incubator (37°C) CO2 incubator Binder GmbH, Tuttlingen, Germany 
Incubator (30°C & 37°C) Heraeus Kelvitron Thermo Fisher Scientific, Waltham, 
USA 
Incubator (35°C) HerA Therm Thermo Fisher Scientific, Waltham, 
USA 
Incubator 15°C TC255  Lovibond 
Incubator 20°C 
 
Thermo Fisher Scientific, Waltham, 
USA 
Laser scanning microscope LSM710 Zeiss, Oberkochen, Germany 
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Laser scanning microscope LSM800 Zeiss, Oberkochen, Germany 
Magnetic stirrer RET basic IKA, Staufen, Germany 
Nanodrop NanoVue Plus Ge Healthcare Buckinghamshire, UK 
PCR cycler Mastercycler Gradient Eppendorf, Hambung, Germany 
pH meter 
 
Mettler Toledo, Ohio, USA  
Pipettes 
 
Brand, Wertheim, Germany 
Pipettor Pipetboy Integra Bioscience, Bibertal, Germany 
Plate Reader  F200 Pro Tecan, Männedorf, Switzerland 
Power suppliers PowerPac HC / Basic Bio-Rad, Hercules, USA 
qRT-PCR 48 well Stepone Realtime 
PRC System 
Applied Biosystems / Thermo Fisher 
Scientific, Waltham, USA 
qRT-PCR 96 well Stepone Plus Realtime 
PCR System 
Applied Biosystems / Thermo Fisher 
Scientific, Waltham, USA 
SDS PAGE System  Mini-PROTEAN cell 
chambers 
Bio-Rad, Hercules, USA 
Shaker (4°C) SM-30 control Edmund Bühler GmbH, Hechingen, 
Germany 
Shaker/Incubator Innova 4230 New Brunswick Scientific/Eppendorf, 
Hamburg, Germany 
Shaker/Incubator Multitron Pro Infors HT, Bottmingen, Switzerland 
Sonicator Sonoplis HD 2070/ 
VW 2070 
Bandelin, Berlin, Germany 
Speedvac SPD1010 Savant Thermo Fisher Scientific, Waltham, 
USA 
Stereomicroscope SMZ 745 Nikon, Tokio, Japan 
Tube roller RS-TR-5 Phoenix Instrument, Garbsen, 
Germany 
Trimmer (EM sections) Leica Microtome Leica, Wetzlar, Germany 
Vacuum pump 
 
KNF Lab, New Jersey, USA 
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Vortexer Vortex-Genie® 2 Scientific Industries, Bohemia, USA 
Water bath  GFL, Burgwedel, Germany 
WB Detection System Lumi-Imager F1TM Boehringer Mannheim GmbH 
WB Detection System Odyssey® Imgage 
System FC 
LI-COR, Lincoln, USA 




Culture plates (8-well) Ibidi, Martinsried, Germany 
Culture plates (6/24/96-well plate) Sigma Aldrich, St. Louis, USA 
Culture plates (35/60/100 mm) Sarstedt, Nümbrecht, Germany 
Falcon tubes 15 and 50 Sarstedt, Nümbrecht, Germany 
Filter tips Sarstedt, Nümbrecht, Germany 
Glass cover slips Carl Roth, Karlsruhe, Germany 
Glass slide 76x26 mm Carl Roth, Karlsruhe, Germany 
Lysing Kit 0.5 ml and 2 ml tubes Bertin instruments, Montigny-le-Bretonneux, 
France 
MicroAmpTM Fast optical 96-well reaction 
plate 
Applied Biosystem by life technologies 
MicroAmpTM Fast optical adhesive film Applied Biosystem by life technologies 
Parafilm Bemis, Neenah, USA 
Pasteur pipettes  (glass) Carl Roth, Karlsruhe, Germany 
PCR tubes (single) Sarstedt, Nümbrecht, Germany 
PCR tubes (stripes)  Kisker Biotech GmbH & Co. KG 
Plates (96 well, transparent) (plate reader) Sarstedt, Nümbrecht, Germany 
Plates (96 well, black) (plate reader) Corning, New York, United States 
Plates (96 well, white) (plate reader) Corning, New York, United States 
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Reaction tubes (1.5 ml) Sarstedt, Nümbrecht, Germany 
Platinic wire Carl Roth, Karlsruhe, Germany 
Reaction tubes (low binding, 1.5 ml) Sarstedt, Nümbrecht, Germany 
Serological pipettes Sarstedt, Nümbrecht, Germany 
Table waste bags Sarstedt, Nümbrecht, Germany 
Tips Sarstedt, Nümbrecht, Germany 
 
6.1.9 C. elegans strains 
Strain name Description Source 
DA2123  
 















CL2006 (dvIs2 (pCL12(unc-54:hu-Aβ 1–42) + pRF4)) 
(integrated) 
CGC 
AM1066 rmIs350 (unc-54p::Q40:: RFP) (integrated) CGC 
AM141 rmIs133 (unc54p::Q40::YFP) (integrated) CGC 
CL2355  smg-1ts (cc546); snb-1::Aβ1−42::long 3′-
UTR) (integrated) 
CGC 
AM101  rmIs110 (F25B3.3p::Q40::YFP) (integrated) CGC 
AM44 rmIs190 (F25B3.3p::Q67::CFP) (integrated) CGC 
DA2123/CL2006 adIs2122 (lgg-1p::GFP::lgg-1 + rol-
6(su1006)) / (dvIs2 (pCL12(unc-54:hu-Aβ 1–
42) + pRF4)) (integrated) 
Kirstein lab 
DA2123/AM1066 adIs2122 (lgg-1p::GFP::lgg-1 + rol-
6(su1006)) / rmIs350 (unc-54p::Q40:: RFP) 
(integrated) 
Kirstein lab 
Material and Methods 
99 
YD3/CL2006 xzEx3 (Punc-54::UbG76V::Dendra2) / (dvIs2 
(pCL12(unc-54:hu-Aβ 1–42) + pRF4)) (non 
integrated) 
Kirstein lab 
YD3/CL2355 xzEx3 (Punc-54::UbG76V::Dendra2) / smg-
1ts (cc546); snb-1::Aβ1−42::long 3′-UTR) 
(non integrated) 
Kirstein lab 
YD3/AM44 xzEx3 (Punc-54::UbG76V::Dendra2) / 
rmIs190 (F25B3.3p::Q67::CFP) (non 
integrated) 
Kirstein lab 
YD12/CL2006 xzEx12 (PF25B3.3::UbG76V::Dendra2) / 
(dvIs2 (pCL12(unc-54:hu-Aβ 1–42) + pRF4)) 
(non integrated) 
Kirstein lab 
YD12/CL2355 xzEx12 (PF25B3.3::UbG76V::Dendra2) / 
smg-1ts (cc546); snb-1::Aβ1−42::long 3′-
UTR) (non integrated) 
Kirstein lab 
MAH240 sqIs17 (hlh-30p::hlh-30::GFP + rol-
6(su1006) (integrated) 
CGC 
RT476 wIs170 (vha6p::GFP::rab-7 + Cbr-unc-
119(+)) (integrated) 
CGC 
RT258  pwIs50 (lmp-1::GFP + Cbr-unc-119(+)) 
(integrated) 
CGC 
N2 Wild type CGC 
 
6.1.10 Mammalian cell lines 
Strain name Description Source 
HEK293 cells Human embryonic kidney cells 293 Claudia Rutz 
(FMP, Berlin, 
Germany) 
HEK293 cells (FlucDM) Human embryonic kidney cells 293 stable 
expressing FlucDM-GFP 
FU Hartl (MPI, 
Martinsried, 
Germany) 
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6.1.11 Bacterial strains and RNAi clones 
Strain – application Genotype  
E. coli OP50 – food source E. coli (Uracil auxotroph) 
E. coli HT115(DE3) – RNAi  E. coli [F-, mcrA, mcrB, IN(rrnD-rrnE)1, rnc14::Tn10(DE3 
lysogen: lavUV5 promoter -T7 polymerase]. 
 
























6.1.12 DNA and siRNA plasmids 
DNA Source  
UbG76V-GFP Katrin Juenemann (FMP, 
Berlin, Germany) 
 
GFP Katrin Juenemann (FMP, 
Berlin, Germany) 
 
HttExon1Q25-GFP  Katrin Juenemann (FMP, 
Berlin, Germany) 
 
Material and Methods 
101 
HttExon1Q97-GFP Katrin Juenemann (FMP, 
Berlin, Germany) 
 
   
siRNA Description Company 
dnaja1 siGENOME SMARTpool Dharmacon/Horizon, 
Colorado, United States 
dnaja2 siGENOME SMARTpool Dharmacon/Horizon, 
Colorado, United States 
dnajb1 siGENOME SMARTpool Dharmacon/Horizon, 
Colorado, United States 
hspa4 siGENOME SMARTpool Dharmacon/Horizon, 
Colorado, United States 
hspa8 siGENOME SMARTpool Dharmacon/Horizon, 
Colorado, United States 
Non-targeting siGENOME SMARTpool  
(Pool #1) 
Dharmacon/Horizon, 
Colorado, United States 
Non-targeting  siGENOME  
(#3, for FlucDM experiments) 
Dharmacon/Horizon, 
Colorado, United States 
 
6.1.13 Software and online tools 
Software Name Company 
Bradford Detection Tecan I-control Tecan, Männedorf, Switzerland 
Data analysis Excel v14.0.7182.5000 Microsoft 
DNA/RNA 
detection 
GeneSys v1.3.1 Syngene, Cambridge, UK 
Image analysis Fiji v2.0.0-rc41 Schindelin et al.  
Microscopy Zen 2010B SP1 v6.0 Zeiss, Oberkochen, Germany 
Orthologe 
prediction 
Blastp NCBI, Bethesda, USA 
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PCR target Tm DINAMELT (Markham et al. 
2005) 
The RNA Institute 
Primer design Primer3 v3 Untergasser et al.  
Primer specificity Primer Blast NCBI, Bethesda, USA 
qRT-PCR 48 well Stepone Software v2.0 Thermo Fisher Scientific, Waltham, 
USA 
qRT-PCR 96 well Stepone Software v2.3 Thermo Fisher Scientific, Waltham, 
USA 
WB detection LumiAnalyst 3.0 Boehringer Mannheim 
WB detection Image Studio v4.0.21 LI-COR, Lincoln, USA 
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6.2 Methods 
6.2.1 C. elegans maintenance 
Nematode strains were kept at 15°C on NGM 60 mm plates seeded with E. coli 
OP50 strain for maintenance. To avoid starvation, five to ten animals were 
placed onto new plates weekly. Animals were kept either on 100 mm, 60 mm or 
35 mm NGM-plates or RNAi plates seeded with OP50 or HT115 (DE3) strains 
(RNAi), respectively, which is indicated in the respective section.  
To synchronize nematodes for experiments, adult animals were placed on 
NGM-plates seeded with OP50 to lay eggs. After, adults were washed from the 
plate with 1x M9, and the eggs were kept on the plate to hatch at 20°C 
overnight. On the next day, L1 larvae were collected and used for the indicated 
experiment.  
For aging experiments, progeny needs to be separated from the older animals. 
Thus, animals were transferred onto new plates from day 4 on until their day of 
harvest. Picking of individual nematodes was performed with a platinum wire 
fixed onto a glass pipette. Wires were sterilized by heat and equipped with 
OP50 (glue), prior to picking. 
When a high number of animals was required (such as for the proteasome 
activity assay), nematodes were grown on several 100 mm plates with the 
indicated food source. To separate the offspring, animals were washed from the 
plate with 1x M9 and transferred to 15 or 50 ml tubes and separated from larvae 
by sedimentation from day 4 on. For further growth, animals were transferred to 
new 100 mm plates. 
 
6.2.1.1 C. elegans male generation and crossing 
Young adult hermaphrodites were incubated at 30°C for 8 h on 60 mm OP50 
seeded NGM plates. Animals were grown to lay eggs at 20°C and offspring 
were scored for male nematodes.  
To generate the following crosses: DA2123/CL2006, DA2123/AM1066, 
YD3/CL2006, YD3/CL2355, YD3/AM44, YD12/CL2006, YD12/CL2355 - 9 
males of one of the strains and 1 L4 larvae of the other strain were transferred 
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to a 35mm OP50 seeded NGM plate at 20°C for mating. The correct 
phenotypes were screened in the next generations.  
 
6.2.1.2 RNA interference in C. elegans 
Synchronized animals were placed onto RNAi plates that were seeded with E. 
coli expressing dsRNAi against hsp-1, hsp-110, hsp-16.41, hsp-17, dnj-12, dnj-
13, and dnj-19 or the empty vector L4440 as a control. The pas-5 knockdown 
was performed as described (Hamer et al. 2010). Depletion of pas-5 leads to 
developmental arrest if animals are treated from the L1 stage on. To overcome 
this developmental arrest, animals were grown on OP50 seeded NGM plates 
until the early L4 stage and then transferred to pas-5 RNAi plates for 72 h. 
 
6.3 Cell culture maintenance 
HEK293 cells were grown in 100 mm dishes and maintained in DMEM medium 
(Gibco) supplemented with 10% fetal calf serum, 1 mM glutamine (Gibco), 100 
U/ml penicillin (Gibco), and 100 μg/ml streptomycin (Gibco) at 37°C supplied 5% 
CO2. To avoid starvation, cells were dissociated from the plate with 1x trypsin-
EDTA (Gibco) and then splitted into new 100 mm plates once a week.   
 
6.3.1 Transfection  
For siRNA-mediated knockdown, cells were seeded with an equal cell number 
in 6-well plate format for 24 h. Then cells were transfected with siGENOME 
SMARTpool (Dharmacon/Horizon) DNAJB1 siRNA, HSPA4 siRNA, DNAJA1 
siRNA, DNAJA2 siRNA and HSPA8 siRNA in a final concentration of 50 nM. 
Non-targeting siRNA (Dharmacon/Horizon) was used as negative control. Cells 
were transfected twice with siRNA (24 and 48 h before harvest).  
To assess the autophagic flux, cells were treated with 200 nM Bafilomycin A1 
(Sigma-Aldrich) 4 h before harvest.  
To analyze the degradation rates of UbG76V, cells were transfected with 2 μg 
plasmid-DNA of UbG76V-GFP cloned into the pEGFP-N1 vector that was 
previously described (Juenemann et al., 2013) for 24 h. As a positive control, 
cells were incubated with 20 μM MG-132 (Sigma-Aldrich) 4 h before harvest.  
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In order to analyze the impact of polyglutamine aggregates on proteasomal 
function, cells were transfected with 2 μg plasmid-DNA of GFP, HttExon1Q25-
GFP, and HttExon1Q97-GFP 24 h prior cell harvest. 
For transfection experiments, cells were transfected with jetPRIME (Polyplus-
transfection) according to the manufacturer's instructions.  
After 48 h cells were harvested into a 15 mL tube and washed 2x with 1mL of 
1x PBS. The samples were analyzed as described in the following sections.  
 
6.3.2 Live cell imaging of luciferase aggregates  
Stable HEK293 cells expressing FlucDM-GFP (Raychaudhuri et al. 2014) were 
seeded in fluorobrite DMEM medium (Gibco) in an 8-well glass bottom plate 
(Ibidi) coated with poly L-lysine (Sigma). Then cells were transfected with siRNA 
(as described above), and imaged with a 40x objective for 48 h in a CSU 
microscope (Nikon) supplied with 5% CO2 at 37°C. As a positive control, cells 
were treated with 20 μM MG-132 (Sigma-Aldrich) and DMSO was used as a 
control. 
 
6.3.3 Luciferase activity 
For luminescence activity experiments, stable HEK293 cells expressing 
FlucDM-GFP (Raychaudhuri et al. 2014) were seeded in 24 well-plates for 24 h 
and then treated with the indicated siRNA. As a positive control, cells were 
treated with 20 μM MG-132 (Sigma-Aldrich), and DMSO was used as a control.  
To measure luciferase activity, the medium was removed from the wells and 
cells were incubated with 200 µL Steady-Glo Luciferase mix (Promega) in the 
indicated time point in the dark at room temperature (25°C) for 10 min. Then 50 
µL (duplicates) of the reaction mix was transferred to a 96-well plate (white, 
bottom white) appropriated for luminescence measurements. Luminescence 
was recorded in a plate reader (Tecan Safire), and the signal was acquired for 1 
sec at 25ºC.  
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6.4 Protein isolation 
6.4.1 C. elegans 
Briefly, 50 animals were washed three times with 1x M9, and the pellets were 
frozen in liquid nitrogen. Then 2x Laemmli loading buffer (50 mM Tris-HCl pH 
6.8, 2% SDS, 15% glycerol, 100 mM DTT, 0.1% bromphenol-blue) was added 
to the samples and incubated with shaking for 10 min at 100°C. Prior to SDS-
PAGE separation, the samples were centrifuged at 5000 rpm for 5 min. 
 
6.4.2 HEK293 cells 
Cells were harvested in lysis buffer (50 mM Tris/HCl pH 7.4, 150 mM NaCl, 
1 mM EDTA, 1 % Triton-X100, supplemented with complete mini protease 
inhibitor cocktail (Roche)) and incubated for 30 min on ice. Prior to SDS-PAGE, 
30 μg of protein were boiled for 5 min with 6x Laemmli loading buffer (350mM 
Tris-HC pH 6.8, 10% SDS, 30% glycerol, 6% β-Mercaptoethanol, 0.3% 
bromphenol-blue). 
 
6.4.3 Western Blot 
A total protein lysate of C. elegans or HEK293 cells was separated in an SDS-
PAGE and transferred to a PVDF membrane (Trans-blot Turbo system, Bio-
Rad).  After blocking the PVDF membrane with 5% milk in TBST, the blots were 
incubated with the following primary antibodies: anti-α-tubulin (1:2000 in 3% 
milk/TBST, Sigma), anti-HSP-1 / HSP-110 / DNJ-12 / DNJ-13 / DNJ-19 (1:5000 
in 3% milk/TBST, Kirstein lab), anti-DNAJB1 1:1000 in 3% milk/TBST), anti-20S 
α-subunits (1:1000 in 1% BSA/TBST, Enzo), anti-LGG-1 / SQST-1/p62 (1:1000 
in 3% milk/TBST, Kirstein lab) and anti-LC3 (1:1000 in 3% milk/TBST, Abcam). 
The secondary antibodies used were: anti-mouse / rabbit HRP (1:10000 / 
1:15000 in 3% milk/TBST, Thermo Fisher) or anti-mouse-Cy3 antibody 
(1:10000 in 3%milk/TBST, Licor). The western blot images were acquired in a 
Lumi-Imager F1 (Boehringer) for HRP detection and in an Odyssey Imaging 
System (Licor) for Cy3 detection. 
The adjustments of brightness and contrast were done in Adobe Photoshop 
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(equal modifications were done for the same experiment), and the relative 
protein amounts (normalized to α-Tubulin) were quantified with Fiji ImageJ 
software. 
 
6.4.4 Antibody generation 
The HSP-17 antibody was generated by immunizing rabbits with the purified 
protein, and the LGG-1 and SQST-1/p62 antibodies were generated by 
immunizing rabbits with a correspondent synthetic peptide (Pineda, Germany). 
For LGG-1 the peptide: PKSKLHDLDKKKYL was used and for SQST-1/p62 the 
peptide: AVPKPAQEPRIPPSPTSALPPPQFFN.  
 
6.5 Compound treatment in C. elegans 
The nematodes were treated with 0.2% DMSO (Carl Roth), 200 μM of 
rapamycin (Sigma), 10 mM chloroquine (Cell Signaling) and 10 mM of 3-
methyladenine (Sigma) in 1xM9 buffer supplemented with OP50 for 18 h in a 
96-well plate at 20°C. To stain the lysosome pool, animals were incubated with 
2 µM LysoTracker-Red DND-99 (Thermo Fisher) using the same conditions as 
described above. 
 
6.6 Microscope imaging 
To image the animals, glass slides with 2% agarose (Bio & Sell) and 0.1% NaN3 
(Carl Roth) in 1x M9 were freshly prepared. The nematodes were mounted onto 
the agarose pads and then imaged. The strains RT258, MAH240 and the 
LysoTracker-Red stained animals were imaged in an EPI-TIRF microscope 
(Nikon) with a 4x objective. The RT476, DA2123 (mounted on 2% agarose with 
2 mM levamisole (Sigma)) and YD3/YD12 (the experimental set-up is described 
below) strains were imaged using a confocal microscope LSM710 (Zeiss) with 
10x or 20x objectives. 
Brightness and contrast of images were adjusted equally between the different 
conditions. Due to high fluorescence intensity, some images were edited 
separately: in figure 3.3 A - hsp-1 RNAi images were edited less for brightness 
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adjustments due to the high fluorescence intensity; in figure 3.8 A – day 10 
images were edited less for brightness adjustments compared to day 4, due to 
the high fluorescence intensity, in addition day 10 hsp-1 RNAi image were 
edited less for brightness adjustment compared to the other knockdowns due to 
the high fluorescence intensity. Fluorescent intensities of RT258, RT476, and 
LysoTracker-Red stained animals were determined for each animal 
(fluorescence was normalized to the area of animal) with Fiji ImageJ software. 
 
6.7 Proteasome capacity 
6.7.1 UbG76V levels - C. elegans and HEK293 cells 
The YD3 and YD12 strains were used to measure the degradation rates of 
UbG76V::Dendra2. The photoconversion was performed as described 
previously (Hamer et al. 2010). Briefly, day 4/7 animals were mounted on 3% 
agarose pads with 0.5 mM levamisole. Photoconversion and imaging were 
performed using a LSM710 microscope. After imaging, nematodes were 
recovered on the respective feeding plate and imaged 3 (YD12) or 24 (YD3) 
hours later. The UbG76V::Dendra2 fluorescence was quantified with Fiji ImageJ 
software. 
A similar approach was used for HEK293 cells. As described above, HEK293 
cells were transfected with UbG76V-GFP, and the UbG76V-GFP levels were 
measured by western blot. 
 
6.7.2 Chymotrypsin-like activity – C. elegans and HEK293 cells 
Proteasome activity assay was performed as previously described (Kisselev et 
al. 2005, Vilchez et al. 2012). Animals were lysed using a Precellys 24 
homogenizer (Bertin Technologies) in lysis buffer (20 mM HEPES, 110 mM KAc, 
2 mM MgAc2, 100 µM Digitonin). Protein concentration was determined by 
Bradford assay (Roti-Quant, Carl Roth) and 25 µg of protein was incubated with 
100 µM of Suc-LLVY-AMC (Enzo) in a 96-well plate (Corning). As a positive 
control, 50 µM of MG-132 (Sigma) was incubated with 25 µg of lysate for 30 min 
on ice before the addition of Suc-LLVY-AMC. A plate reader (Tecan Safire) was 
used to monitor the fluorescence (380ex/460em) with measurements every 5 
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min for 2 h at 25°C. Each measurement for each condition was performed in 
duplicates. 
A similar experimental procedure was applied for HEK293 cells. Some 
adjustments were done, 10 µg of protein were used in the experiments and the 
measurements were performed at 37°C. For proteasome inhibition, 20 µM of 
MG-132 was incubated with 10 µg of protein. 
The slope (in the linear phase) was used to calculate the relative activities and 
then normalized to the control condition. 
 
6.8 Electron microscopy and correlative-light electron microscopy 
Nematodes were cryofixed by high pressure freezing using the HPM100 
instrument in bacteria (OP50) for cryoprotection. For CLEM, nematodes were 
freeze substituted (FS) in acetone plus 0,1% uranyl acetate, 0,1% tannic acid, 
0,05% glutaraldehyde, 0,5% H2O (at -90 C). Following FS, animals were 
washed in pure acetone and infiltrated with HM20 resin/acetone mixes (1:2; 1:1; 
2:1) and pure HM20 changes 2 h each plus pure HM20 last change overnight 
(all steps were carried out at -45°C). UV induced polymerization was done for 
72 h (-45 to -5°C). 
FS program: 5 h -90°C; 9 h increase from -90 to -45 (5°C per h); 24 h -45°C; 48 
h -45 plus UV light; 8,5 h increase from -45 to -5 plus UV light; -5°C 16 h plus 
UV light. 
Polymerized blocks where trimmed and ultrathin sectioned onto the Finder grids 
(Plano). After DAPI staining, grids were positioned into the imaging chamber in 
PBS/glycerol (10%) solution. Sections were imaged with LSM800 equipped with 
an AIRYscan detector. Retrieved grids were contrasted with uranyl acetate and 
lead citrate and imaged at Zeiss 900 microscope. DAPI specific (nuclei, bacteria) 
and cytoplasmic background staining were used to correlate LSM images with 
EM images. 
For regular Epoxy embedding, nematodes were freeze substituted in acetone, 1% 
osmium, 0,1% uranyl acetate, 0,1% glutaraldehyde (FS program from -90°C to 
0°C in 36 h). After FS, nematodes were washed in 100% acetone and infiltrated 
with Epoxy resin/acetone (1:2; 1:1; 2:1) followed by changes of pure Epoxy 
resin and polymerization at 60°C. 
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6.9 Relative mRNA quantification 
6.9.1 RNA isolation 
Total RNA was extracted with TRIzol reagent (Invitrogen). Adult animals (day 4 
and older) were dissolved in 250 μl TRIzol, vortexed for 1 min and 20 min at 
room temperature and 4°C, respectively, and incubated for 12 min on ice. After 
the addition of 50 μl chloroform, the samples were inverted for 15 sec and 
incubated for 3 min at room temperature. For further phase separation, samples 
were centrifuged at 12 000 rpm for 15 min at 4°C. RNA from the aqueous phase 
was mixed with 300 μl of 70% ethanol and was purified using NucleoSpin®RNA 
kit (Macherey-Nagel) according to manufacturer’s instructions. The quality of 
the isolated RNA was evaluated by agarose gel electrophoresis and 
measurements of the 260/280 nm as well as 260/230 nm absorption ratios 
(Desjardins et al. 2010).  
 
6.9.2 cDNA synthesis 
500 ng of RNA were reverse transcribed using Maxima First Strand cDNA 
Synthesis Kit for qRT-PCR (Thermo Scientific). For control, samples without the 
reverse transcriptase enzyme, 250 ng RNA were used in 10 μl aliquots. 
 
6.9.3 Primer design and validation 
Primers for qRT-PCR were designed using the Primer3 software and tested for 
specificity and amplicon secondary structures using NCBI primer blast, 
DINAMelt Web Server, melting curves and agarose gel electrophoresis of PCR 
products (Markham et al. 2005, Thornton et al. 2011). In order to use the 2-
ΔΔCt method, amplification efficiencies of the gene of interest (GOI) and the 
reference gene (RG) have to be equal. Suitable primer concentrations for the 2-
ΔΔCt method were validated by dilution series of different cDNA amounts 
(undiluted to 1:1000-fold) of mixed cDNA samples (Livak et al. 2001). Primer 
concentrations were defined as suitable if the slope of ΔCt (CTgoi-CTref) vs. log 
(cDNA) was less than 0.1 (absolute value) (QIAGEN 2010). 
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6.9.4 qRT-PCR 
Quantitative RT-PCR was performed using Luminaris Color HiGreen High ROX 
qPCR Master Mix (Thermo Scientific) in 20 μl reactions. 2 μl of a 1:10 diluted 
cDNA solution were analyzed in a two-step cycling protocol according to 
manufacturer’s instruction of the Master Mix with a StepOneTM Real-Time PCR 
System and StepOneTM Software version 2.0 as well as StepOnePlusTM Real-
Time PCR System and StepOneTM Software version 2.3 (Applied Biosystem, 
life technologies). Relative expression of GOI mRNA expression was calculated 
with the 2-ΔΔCt-method (Livak et al. 2001). Ct-value duplicates were measured 
in three independent batches and averages of the duplicates were referred to 
the internal control cdc-42 to obtain ΔCt. Averaged ΔCt values (3 batches) were 
normalized to average ΔCt of control samples to obtain ΔΔCt. Standard 
deviations were calculated from the ΔCt values of the three different batches. 
Fold changes were obtained by the formula: relative mRNA level = 2-(ΔΔCt 
SDΔC). In case of high expressional variation within the same sample in three 
independent batches, relative mRNA levels of the individual batches were 
averaged.  
 
6.10 Statistical analysis 
The data was analyzed with ANOVA to test for statistical significance. p values 
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